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CHAPTER 1 
INTRODUCTION 

Introduction 
The eye disease "glaucoma" was first described in Hippocrates' Aphorisms 
about 400 BC (glaukosis) as an ailment of old men.! However, it was not fut1her 
explained and nobody was certain about the meaning of the word. Probably 
cataract was part of the diseases summarized by Hippocrates as glaukosis, next 
to the disease nowadays known as glaucoma. Several hypotheses were formed 
many years later. One of these explanations referred to the Greek word glaucos, 
meaning glaze 2, later more specified as a greenish glaze of the lens.! On 
examination with in that time available light 'equipment', a greenish light reflex 
could be seen, and this green light reflex became a prominent sign in the 
medical literature of that time.3 Another suggestion for the derivation of the 
word glaucoma was from the Greek word glaux, meaning owl, those days the 
symbol of the goddess Athena; the dilated and oval pupil in acute glaucoma 
resembled the shape of the pupil of an owl-eye.4 
The name glaucoma was applied to a condition or disease with an 
abnormality in the pupillaty area (a change in color andlor shape), inescapably 
leading to total blindness.3 The Greek new that some of these conditions could 
be cured and others not by surgical removing the lens.' Inflammation as cause 
of glaucoma was stressed in 1722 by Charles Saint-Yves in his textbook.6 He 
related glaucoma to an acute inflammation of all coats of the eye but the 
conjunctiva, mostly accompanied by severe pain. '. 6 In 1708 Hermann 
Boerhave described impairment of the aqueous drainage of the eye as the cause 
of glaucoma. 
Inflammation remained a major sign in glaucoma over the next years until 
1862 when Donders published his classical paper in which he made a division 
in two different types of glaucoma: glaucoma simplex, and glaucoma cum 
ophthalmia.' Glaucoma simplex was a disorder with increasing tension of the 
eye, excavation of the disc, shift of the vessels in the disc, loss of visual field 
and loss of vision without any symptoms of elevated intraocular pressure and 
clear ocular media often for years after complete blindness. Probably it was the 
same disorder as the "blindness with optic disc exca~ation" of Von Graefe.' 
Previously this condition was not regarded as a member of the glaucoma family. 
9 
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Anterior chamber fluid hydrodynamics were first described in 1702 by 
Jacobus Hovius in his dissertation. However, elevated intraocular pressure was 
already known by the Arabs in the 10'" century (AI Tabari), and in 1626 by 
Banisterl, but only after the publication of the work of Antoine-Pierre Demours 
(1818) the concept of elevated intra-ocular pressure in glaucoma became fully 
established.6 In England Mackenzie mentioned this in 1830.6 For nearly 150 
years thus emphasis was put on the intraocular pressure in the diagnosis of 
glaucoma, only later to be followed by the appearance of the optic disc and the 
shape and amount of visual field loss. Digital tonometry became a special skill 
of ophthalmologists of that time. In the late 1800s mechanical tonometers were 
developed, but they were all difficult and awkward to use. In 1905, Schi0tz 
introduced his more practical indentation tonometer, which remained the 
instrument of choice for about 50 years. Next, in 1955, Goldmann introduced 
his applanation tonometer. This instrument avoided the artifacts of the Schi0tz 
tonometer and still is the standard device for measuring intraocular pressure.' 
From 1853 on, the year of the introduction of the ophthalmoscope, a more 
extensive investigation of the eye was possible, and changes in the appearance 
of the optic disc in glaucoma patients were recognized. The observation of a 
depression in the center of the optic disc, firstly mistaken as a swelling by 
Jaeger and von Graefe, was interpreted as an effect of elevated intraocular 
pressure. From that time on, more studies were performed to investigate the 
etiology of glaucoma.3• 6 Nowadays, ophthalmoscopy gradually has been 
replaced by (stereo) fundus photography when evaluating the optic disc for 
glaucoma research. Only in the last decade, new techniques have been 
developed to study the optic disc, using laser scanning devices or computerized 
digital analysis techniques based on conventional stereoscopic topographical 
data of the optic disc. All are focused on standardized quantification of 
glaucomatous damage of the optic disc. However, there can be considerable 
differences in the results ofthe various techniques.'-13 
Methods for more or less accurate visual field testing were available since 
the mid-1800s. In 1856, von Graefe was the first to use a primitive campimeter 
to plot paracentral defects in the visual field. In 1889 Bjerrum introduced a 
10 
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more quantitative method of perimetry, which became the standard for the next 
40 years. In 1950, again Goldmann introduced his bowl perimeter. In the 1980s 
computerized perimetry was introduced, resulting in better standardization and 
sometimes a higher sensitivity in detecting small visual field defects, such as 
with blue stimuli on a yellow background. However, these testing programs 
require a cooperative patient and can be 
fatiguing, particularly in the elderly, which 
can result in attifactual field defects. Definite 
decisions about the presence of glaucomatous 
visual field test results must still be based on 
the judgement of skilled clinicians, with 
inherent variability.' 
Today glaucoma is defined as a disease 
(in which the intraocular pressure may be 
relatively too high for proper oxygenation of 
the eye and its ganglion cells) causing an 
optic neuropathy characterized by cupping of 
the optic disc with an associated visual field 
defect. 14 There are several types of glaucoma. 
C .r. ·.r J • I b They are classified according to age of onset: O1!JlguratlOlI OJ t ze anterIOr C Jalll er 
angles. a: normal angle; b: narrow congenital vs. adult onset; etiology: primary 
angle. d d I h . I . vs. secon aty; an pat lOp ySlO OglC 
mechanism: open vs. closed angle. Congenital glaucoma most often is an 
autosomal recessive hereditaty disorder. 15 Primaty glaucoma is due to largely 
unknown mechanisms, and hereditary factors probably play a role in its 
etiology. Secondary glaucoma can arise from a large variety of injuries, 
medication, systemic disorders, or ocular diseases that affect the outflow 
channels. The terms open angle and closed angle refer to the configuration of 
the anterior chamber angle in the eye. In open angle glaucoma the anterior 
chamber angle has a normal configuration, but the flow through the trabecular 
meshwork is hampered. In closed angle glaucoma the root of the iris lies against 
the normal trabecular meshwork and prevents aqueous outflOW. 14 
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Primary open angle glaucoma is the most prevalent type of glaucoma in 
Western countries. 16 Its prevalence rises with ageing, which was already 
demonstrated in a clinic-based population by Donders in 1861 (see table).' 
P.'evalence of simple glaucoma according to age and gender.' 
Age in years Male Female Total 
20 - 30 2 
30 - 40 4 5 9 
40 - 50 7 9 16 
50 - 60 17 28 45 
60 -70 10 12 22 
70 - 80 0 
39 56 95 
The early detection of glaucoma is an important public health concern 
because there is evidence that, unlike many other forms of blindness, 
glaucomatous blindness may be prevented in cases with elevated intraocular 
pressure if the disease is treated adequately and if treatment is begun in time. 
However, once vision has been lost, it cannot be restored at present time by any 
form of treatment. UnfOliunately, most patients with early glaucoma are 
asymptomatic, and much peripheral vision can be lost before the patient notices 
visual impairment. This means that only with routine screening of 
asymptomatic people early glaucoma cases can be detected. In the past this 
screening mainly was based on intraocular pressure measurement 17, and a 
cutoff point of 21 mmHg was used, based purely on statistical grounds. 18•20 
Leydhecker found in 0.5% of all eyes of 10.000 healthy subjects an intraocular 
pressure higher than 22.4 mmHg (Schiotz 3.5/5.5) and labeled them as 
"Glaukomverdacht". Today, with more advanced techniques, more emphasis is 
12 
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given to optic disc appearance, visual field examination, and nerve fiber layer 
abnormalities. 
Von Graefe described hereditary glaucoma that had been already more 
often mentioned by earlier authors. He attributed it to inflammatory glaucoma 
and mentioned that the disorder often started earlier in the next generation, 
something we now would call anticipation. In Berlin he knew several families 
with glaucoma for three to four generations. He also mentioned that one still 
does not know much about the etiology of glaucoma, a situation still valid 130 
years later!21 
This thesis focuses on (primaty) open-angle glaucoma. All studies were 
performed based on data from examinations of subjects from the Rotterdam 
Study, a population-based cohOlt study of subjects aged 55 years and over. In 
chapter 2 the definitions and prevalences of open-angle glaucoma in this 
population are described. Also the prevalence of visual field defects and its 
causes are described (chapter 3). First-degree relatives of glaucoma cases were 
examined, together with first-degree relatives of an age and gender matched 
control group. The prevalence figures of primary open-angle glaucoma in both 
groups of relatives was compared to study the effect of genetic factors (chapter 
4). A technique, creating the possibility for accurate detection of damage to the 
optic nerve over time, was compared with standard ophthalmoscopy and is 
described in chapter 5. The influence of corneal thickness on the intraocular 
pressure measurement is discussed in chapter 6. Chapter 7 deals with the risk of 
inducing acute angle-closure glaucoma in a screening protocol for glaucoma. 
Finally, chapter 8 places the results of the previous studies in a larger 
perspective, discusses methodological considerations in relation to the previous 
studies and gives some suggestions for future research, followed by a summary 
in chapter 9. 
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CHAPTER 2 
CHANGING VIEWS ON 
OPEN-ANGLE GLAUCOMA 
DEFINITIONS AND PREVALENCES 
ABSTRACT 
Purpose: To quantify in a masked way the prevalence of determinants of open-
angle glaucoma (OAG) and their influence on the overall OAG prevalence. 
Methods: A total of 6781 subjects aged 55 years or over pmticipated in this 
population-based study (6293 independently living subjects and 488 living in 
nursing homes). The criteria for the diagnosis of OAG were based on semi-
automated measurements of the optic disc (vertical cup-to-disc ratio (VCDR), 
minimal width of neural rim, or asymmetry in VCDR between both eyes) and 
visual field testing with kinetic Goldmann perimetry. All separate criteria for 
the diagnosis of OAG were assessed independently of each other. 
Results: Mean VCDR was 0.49, and the 97.5 'h percentile was 0.70. The 
prevalence of visual field defects compatible with OAG and without other 
causes was 1.5%. Overall prevalence of OAG in the independently living 
subjects was 0.9% (95% Cl 0.6, I.l; 56 cases). Prevalence of OAG was almost 
three tilnes higher in men than in women (Odds ratio 2.3, 95%CI 1.2,4.5). The 
risk of OAG increased with 8% per year of age (95% CI 4.0%, 13.0%). 
Different commonly used criteria for diagnosis of OAG resulted in prevalence 
figures ranging from 0.1 % to 1.2%. 
Conclusion: The overall prevalence of OAG in the present study was 0.9%. 
The prevalence was higher in men than in women and increased with age. 
Prevalence figures differed by a factor 12 when using different criteria to define 
OAG. Diagnostic standardization is necessary for comparison of epidemiologic 
glaucoma studies. 
Open-Angle Glaucoma; Definitions and Prevalences 
Primary open-angle glaucoma (pOAG) ranks third in causes of visual 
impairment in the Western world. I·' Despite this and prevalence figures in white 
subjects ranging from 0.8% to 3.0%1.4.12, little is known about its etiology. This 
may be pattly due to the lack of a world-wide epidemiological definition of, or 
standard for diagnosis of POAG. As a result many (epidemiologic) stlldies are 
difficult to compare, due to the different criteria and methods used for 
diagnosis, hampering meta-analyses. 
It is nowadays generally accepted that POAG is an optic neuropathy 
characterized by cupping of the optic nerve head, with nerve fibel' loss and 
corresponding visual field defects. An elevated intraocular pressure (lOP) is 
considered to be a risk factor for POAG, as well as the presence of a first-degree 
relative with glaucoma.13 
There have been relatively few population-based prevalence studies on 
POAG (Ferndale\ Framingham', Dalby", Baltimore', Beaver Dam', Barbados·, 
Blue Mountains", and Ponza12). The ophthalmological division of the 
Rotterdam Study focuses on POAG, and results of a prevalence study in a 
subset of the examined population using different criteria for POAG have been 
published before. 1O For the diagnosis POAG congenital forms of glaucoma have 
to be excluded, as well as secondary causes of glaucoma as pseudo exfoliation. 
Because we did not specifically exclude pseudoexfoliation at baseline, we will 
further write about open-angle glaucoma (OAG) instead ofPOAG. 
The aim of the present study was to quantify independently the prevalence 
of determinants of OAG in a general Caucasian population, and to study the 
influence of various criteria for OAG on this prevalence. 
MATERIALS AND METHODS 
PoplIlatioll 
The present study was performed as a part of The Rotterdam Study, a 
prospective cohOlt study of all residents, aged 55 years and over, living in a 
suburb of Rotterdam, The Netherlands. The objective of the Rotterdam Study is 
to investigate determinants of chronic disabling cardiovascular, neurogeriatric, 
locomotor and ophthalmologic diseases. 14 The study has been approved by the 
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Table 1. Responsefigures of the Rotterdam Study, 1990-1993 
Age-category (years) 55-59 60-64 65-69 70-74 75-79 80-84 85-89 90+ TOTAL 
Independent living subjects: 
Total eligibles 1480 1761 1737 1606 1286 799 404 88 9161 
Total examined 1172 (79.2) 1421 (80.7) 1327 (76.4) 1157 (72.0) 834 (64.9) 417 (52.2) 141 (34.9) 25 (28.4) 6494 (70.9) 
OphthaImologically 
examined 1164 (78.6) 1401 (79.6) 1281 (73.7) 1108 (69.0) 798 (62.1) 394 (49.3) 124 (30.7) 23(26.1) 6293 (68.7) 
men 483 (75.1) 616 (79.1) 595 (76.6) 452 (69.5) 315 (63.0) 128 (50.6) 32 (32.7) 6(23.1) 2627 (70.5) 
women 681 (81.4) 785 (79.9) 686 (71.5) 656 (68.6) 483 (61.5) 266 (48.7) 92 (30.1) 17(27.4) 3666 (67.5) 
Nursing homes: 
Total eligibles 1 4 14 29 125 282 375 284 1114 
Total examined 1 (100) 3 (75.0) 12 (85.7) 20 (69.0) 72 (57.6) 181 (64.2) 215 (57.3) 13l (46.1) 635 (57.0) 
OphthaImologically 
examined 0(0.0) 1 (25.0) 8(57.1) 12 (41.4) 61 (48.8) 144 (51.1) 156 (41.6) 106 (37.3) 488 (43.8) 
men 0(0.0) o (0.0) 4 (50.0) 4 (50.0) 18 (48.6) 43 (62.3) 37 (52.9) 16 (51.6) 122 (54.5) 
women 0(0.0) 1 (33.3) 4 (66.7) 8 (38.1) 43 (48.9) 101 (47.4) 119 (39.0) 90 (35.6) 366 (41.1) 
Numbers between brackets are percentages of the number eligible subjects in each age-category. 
Open-Angle Glaucoma; Definitions alld Prevalences 
Medical Ethics Committee of the Erasmus University and a written informed 
consent was obtained from all participants. 
All residents were asked to participate in an extensive home interview, after 
which an appointment was made for a medical examination, including a 
complete ophthalmological examination. Interview data were collected for 78% 
(n=7983) of the eligible persons (N=1O,275). The overall response rate for the 
center visit was 69% (n=7129). In Table I the absolute numbers of subjects are 
shown in the different age-categories as are the numbers of examined subjects 
living in nursing homes. In the nursing homes only a limited ophthalmological 
examination was possible; especially visual field screening was umeliable or 
impossible in the institutionalized subjects, mainly due to physical and mental 
disabilities. 
Table 2. Opfltltalmological examinatioll - Rotterdam Study, 1990-1993 
Phase I: 
Autorcfraction 
Visual acuity 
Slitlamp examination 
Keratometry 
lOP measurement 
Visual field screening 
Photographs macular area 
Stereo photographs optic disc 
Ophthalmoscopy 
Phase II: 
Visual field screening 
Phase III: 
Visual field screening 
lOP measurement 
Gonioscopy 
. Tokyo Optical Co, Tokyo, Japan 
t Haag Streit, Bern, Switzerland 
I Zeiss, Oberkochen, Gennany 
Topeon RMA 2000' 
Lighthouse Visual Acuity Chart 
(2nd edition) 
Topcon SL~3E slitiamp' 
Topcon OM~4 Ophthalmometer' 
Goldmann applanation tonometert 
modified 76 M point suprathreshold screening tcst central 25 
degrees (Humphrey Visual Field Analyzer)t 
35° field; TRC·50VT camera' 
200 field; TRC-SS2 camera' 
Direct and indirect (AusJena ophthalmoscope, bonoscope) 
modified 76-point slIprathreshold screening test central 25 
degrees (Humphrey Visual Field Analyzer)1 
kinetic Goldmann perimetryt 
Goldmann applanation tonometer' 
Goldmann 3-mirror contactlenst 
21 
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Measurements 
The ophthalmological screening (Table 2) was performed in three phases by 
three ophthalmologic residents and two technicians. 
The first phase was focused on visual acuity, anterior chamber angle 
depth l5 , and IOP.16 The visual fields of both eyes were screened using a slightly 
modified 76-point suprathreshold test (Humphrey Visual Field Analyzer, Zeiss, 
Germany): only the centni! 52 points of the visual field were tested, reducing 
examination-time and also the chance on rim-artifacts. Three or more 
contiguously missed points on the screening test (blind spot excluded) were 
taken as evidence for a visual field defect. After perimetry, mydriatics were 
administered in both eyes (tropicamide 0.5 percent and phenylephl'ine 5 
percent), irrespective of the anterior chamber angle depth or history of 
glaucoma. 17 Simultaneous stereoscopic fundus color transparencies of the optic 
disc were made (Kodak Rochester, New York, USA), and direct ophthal-
moscopy was performed to assess the vertical cup-to-disc ratio (VCDR). 
Finally, one drop of thymoxamine-hydrochloride 0.5% was administered in 
both eyes to counteract the mydriatic eye drops. 
In the second phase of the glaucoma screening, about two weeks later, 
visual fields were retested with the same screening test in subjects who had 
either a visual field defect or an unreliable visual field test in the first phase. 
In the third phase, some more weeks later, subjects with a visual field defect 
or unreliable field test in the second phase of the study, underwent kinetic 
Goldmann perimetry on both eyes, performed by a skilled perimetrist. Also, in 
cases with a glaucomatous visual field defect gonioscopy was performed 
(PTVMdJ) using a Goldmann thl'ee mirror lens to classify the anterior chamber 
angle according to Shaffer's grading system. 
Due to logistics, subjects underwent a glucose tolerance test (by the 
cardiovascular research group) about twenty minutes prior to lOP measurement 
in the first testing phase. This glucose tolerance test was carried out by giving 
an oral glucose load of 75g in 200 ml of water, and was performed on all non-
diabetic subjects. In a separate study it was found that the median lOP was 
lowered by 1.5 mmHg by this glucose load. lo 
22 
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Optic disc measurements and gradillg 
Stereo transparencies from both eyes of all individuals were digitized and 
analyzed by two technicians with the Topcon image analyzer Imagenet, using 
the module for the retinal nerve fiber layer height. The system's hardware, its 
software modules and reproducibility of measurements have been described 
previously. IS. 19 
In subjects with complete semi-automated measurements, we considered a 
VCDR ;, 0.7, or an asymmetric VCDR ;, 0.3 between both eyes, or a minimal 
neural rim width < 0.1 0, as disc abnormalities suspect for OAG. In subjects 
without semi-automated measurements, we also considered a VCDR ;, 0.7 or 
asymmetty ;, 0.2 between both eyes estimated by ophthalmoscopy, as disc 
abnormalities suspect for OAG. Neural rim width was not ophthalmoscopically 
assessed. The cut-off points were based on the 97.51h percentiles of the 
distributions of the parameters. 
Visual field gmdillg (lml classificatioll 
All Goldmann visual field charts were independently graded by six different 
graders (three senior ophthalmologists, two residents, one perimetrist). Graders 
were masked for all clinical data and optic disc appearances. For fields with 
inconsistent classifications a consensus was reached by four graders. 
Classification of the defects was solely based on the shape and localization of 
the defect (e.g. nasal step, paracentral defects, arcuate scotomas, central rests, 
remaining peripheral islands, temporal nerve fiber bundle defects). All nerve 
fiber bundle defects were considered to be glaucomatous visual field defects 
when not explainable by other (neuro )ophthalmologic abnormalities. For 
exclusion of non-glaucomatous causes of field defects all other data available 
in The Rotterdam Study was used, including questionnaire data, fundus and 
optic disc photographs, neurological examination, and (history) data from 
general practitioners. 
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Criteri(//or OAG ill tlte Rotterd(/m Study 
Definite OAG was defined as presence of a glaucomatous visual field defect, in 
combination with an optic disc suspect for glaucoma (see Optic Disc 
Measurements and Grading section). Probable glaucoma was defined as the 
presence of visual field abnormalities on the Goldmann fields, not explainable 
by other causes, but with optic disc characteristics falling in the normal range, 
or as an optic disc suspect for OAG without visual field abnormalities. The lOP 
was not used as a criterion for OAG, nor was the use of lOP lowering 
medication or the performance of an lOP lowering operation in the absence of a 
visual field defect. At baseline pseudo exfoliation was not explicitly ruled out 
and a few cases with this syndrome might be included in the OAG group. 
Ocular hypertension was defined as an lOP> 21 mmHg or lOP lowering 
treatment in the absence of a visual field defect or optic disc abnormalities 
suspect for OAG. 
Finally, definitions of definite OAG used in other population based studies 
(Table 3) were, when available in the literature, applied to our data. 
D(/t(/ (/II(/lysis 
The distributions of lOP, VCDR, as well as the distribution of asymmetry in 
VCDR and minimal rim ratio of the semi-automated optic disc measurements 
were calculated. We calculated the influence of the glucose tolerance test on 
lOP with linear regression analysis. The prevalence of lOP lowering treatment 
was studied in different age-categories. 
Prevalence figures of definite and probable OAG were calculated by 5 year 
age-categories and by gender. To estimate the risk of age and gender on OAG, 
logistic regression analysis was used with the odds ratio serving as an 
approximation of the relative risk. Sensitivity and specificity values of different 
cut-off points of VCDR, with or without elevated lOP, for the presence of a 
glaucomatous visual field defect were calculated. 
All analyses were adjusted for age and gender when appropriate, and 
performed separately in the independently living subjects and in those living in 
nursing homes. 
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Table 3. Different criteria for (definite) Open-Angle Glal/coma. 
FRAMINGHAM STUDY 22 
• Visual field defect not explainable by other cases, 
combined with 
• VCDR:? 0.6, or asymmetry in VCDR between both eyes ~ 0.2. 
BALTL'IORE EVE SURVEY 9 
• Visual field defect not explainable by other causes, 
or 
• VeDR > 0.8, or asynllnetry in veDR between both eyes> 0.3, 
or a neuroretinal rim width < 0.15. 
BEAVER DAM EVE STUDY 8 
At least two of the following criteria: 
• Visual field defect not explainable by other causes, 
• VCDR 2: 0.8 or an asymmetry in VCDR ;:.: 0.2, 
• IOP:<-: 22 mmHg or treatment 
BLUE I\IoUNTAINS EYE STUDY II 
• Visual field defect not explainable by other causes, 
combined with 
• VCDR 2: 0.7, or asymmetry in VCDR between both eyes L. 0.3. 
ROrTERDAM STUDY (1999 CRlTERL\) 
• Visual field defect not explainable by other catlses, 
combined with 
• VCDR ~ 0.7, or asymmetry in VCDR between both eyes ~ 0.3, or 
minimal rim width < 0.10 with semi~automated measurements, 
or VCDR ;>: 0.7 or asymmetry in VCDR ~ 0.2 on ophthalmoscopy. 
RESULTS 
Table 1 shows the response figures of the prevalence phase of the Rotterdam 
study, focused on the ophthalmological examinations. Tables 2 and 3 
summarize the ophthalmological examinations in this study and the different 
definitions for OAG used in other population-based studies. Table 4 shows the 
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available ophthalmological data on independently living and nursing home 
subjects; the latter data were less complete. Especially the availability of 
grad able optic disc photographs was low in this subgroup. 
Table 4. Available oplttllalmological baselille data witll regard to OAG ill tile 
Rotterdam Stlldy, 1990-1993 
Independently living Nursing home 
subjects subjects 
N (%) N (%) 
SUBJECTS EXAMINED 6293 488 
Applanation tonometry 
Reliable data on both eyes 6214 (98.7) 451 (92.4) 
only one eye 23 (0.4) 10 (2.0) 
No applanation tonometry 56 (0.9) 27 (5.5) 
Optic disc 
Ophthalmoscopic estimates oj VCDR 
Available on both eyes 6154 (97.8) 443 (90.8) 
only one eye 45 (0.7) 27 (5.5) 
No ophthalmoscopic VCDR available 94 (1.5) 18 (3.7) 
Stereo optic disc photographs 
Oradable photographs of 
both eyes 5025 (79.9) 215 (44.1) 
only one eye 656 (10.4) 92 (18.9) 
No gradable photographs available 612 (9.7) 181 (37.1) 
Visual field screening: 
Complete screening both eyes 5983 (95.1) 
Only partial or no screening 310 (4.9) 
The cumulative distribution of lOP is shown in Figure I. There were no 
significant differences between independently living subjects and subjects in 
nursing homes, nor between men and women, and there was no clinically 
significant change in lOP with increasing age. Mean lOP was 14.5 mmHg (95% 
CI 14.4, 14.6; after exclusion of subjects with lOP lowering treatment) and the 
upper limit of normality (97.5th percentile) was 21 mmHg (i.e. an lOP > 21 
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Figure 1. CUlllulative distribution and 97.5'" percentile of the intraacular pressure in 
6293 independently living subjects. 
mmHg was statistically abnormal). The prevalence figures of elevated lOP (> 
21 mmHg) are shown in Table S for the independently living subjects. Men had 
a higher risk of having an lOP> 21 mmHg compared to women (Odds ratio 
lAO, 9S% CI 1.04, 1.96), and also a higher risk of having lOP lowering 
treatment (Odds ratio 1.3, 9S% CI 1.0, 1.7). Ocular hypertension was present in 
4.S% of the independently living subjects, and was more prevalent in men than 
in women (Odds ratio 1.36, 9S% CI 1.06, 1.73). Subjects in nursing homes did 
not differ significantly from independently living subjects concerning 
prevalence figures of elevated lOP and lOP lowering treatment (data not 
shown). The effect of the glucose tolerance test on lOP was studied by 
comparing the lOP between subjects who had undergone a glucose tolerance 
test with subjects who had not. Subjects who had undergone a glucose tolerance 
test had a significantly lower mean lOP (-I.IS mmHg, 9S% CI -lAS, -0.8S). 
After correction for the lOP lowering effect of the glucose solution, the mean 
lOP was IS.6 mmHg (9S% CI IS.S, IS.7), with an upper limit of normality of 
22mmHg. 
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Table 5. Prevalence figures of elevated lOP and lOP lowering treatment. 
Men Men Men 
Age IOP>21 IOP Ocular 
(years) mmHg lowering byper-
(%)" treatment tension 
(%) (%)1 
55-59 10/472 (2.1) 7/483 (1.4) 13/478 (2.7) 
60-64 23/593 (3.9) 19/616 (3.1) 33/604 (5.5) 
65-69 211560 (3.7) 28/595 (4.7) 38/581 (6.5) 
70-74 10/422 (2.4) 27/452 (6.0) 22/439 (5.0) 
75-79 8/297 (2.7) 18/315 (5.7) 15/309 (4.9) 
80+ 10/151 (6.6) 141166 (S.4) 13/159 (S.2) 
Total 8212495 11312627 134/2570 
(3.3) (4.3) (5.2) 
rop had to be higher than 21 mmHg in at least onc eye . 
• Subjects with lOP lowering treatment were excluded. 
Women Women Women 
IOP>21 IOP Ocular 
mmHg lowering hyper-
(%)" treatment tension 
(%) (%)1 
17/664 (2.6) 11/681 (1.6) 26/674 (3.9) 
141764 (1.8) 131785 (1.7) 201774 (2.6) 
10/660 (1.5) 24/686 (3.5) 22/675 (3.3) 
15/623 (2.4) 26/656 (4.0) 26/638 (4.1) 
13/445 (2.9) 33/483 (6.8) 311468 (6.6) 
14/345 (4.1) 241375 (6.4) IS/359 (5.0) 
83/3501 131/3666 143/3588 
(2.4) (3.6) (4.0) 
Total Total Total 
IOP>21 IOP Ocular 
mmHg (%)~ lowering hyper-
treatment tension (%) t 
(%) 
27/1136 (2.4) 1811164 (1.5) 39/1152 (3.4) 
3711357 (2.7) 3211401 (2.3) 53/1378 (3.8) 
31/1220 (2.5) 5211281 (4.1) 60/1256 (4.8) 
25/1045 (2.4) 5311108 (4.8) 4811077 (4.5) 
211742 (2.8) 511798 (6.4) 461777 (5.9) 
24/496 (4.8) 38/541 (7.0) 31/51S (6.0) 
165/5996 244/6293 277/6158 
(2.8) (3.9) (4.5) 
t Ocular hypertension was defined as an lOP higher than 21 mmHg or lOP lowering treatment in at least one eye, in combination with normal visual field tests and without optic 
disc abnormalities suspect for OAG. 
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Table 6. Prevalellce figures of semi-automated alld ophthalmoscopic optic disc 
characteristics in independently living subjects 
Mean VCDR 
Median asymmetry in VCDR 
Mean minimal neural rim width 
Disc characteristics 
VCDR> 
Asymmetry in 
0.4 
0.5 
0.6 
0.7 
0.8 
VCDR> 0.2 
Minimal nCliral 
0.3 
0.4 
rim width < 0.25 
0.20 
0.15 
0.10 
0.05 
Semi -automated 
measurements (SE) 
0.49 (0.0018) 
0.06 
0.17(0.001) 
Ophthalmoscopic 
estimates (SE) 
0.30 (0.0024) 
0.00 
not assessed 
Percentage of subjects 
77.2 
52.8 
23.2 
3.4 
0.2 
6.9 
1.2 
0.1 
84.5 
63.1 
28.9 
4.8 
0.1 
39.1 
16.9 
7.3 
3.2 
l.0 
4.4 
1.3 
0.6 
not assessed 
not assessed 
not assessed 
not assessed 
not assessed 
The distributions of semi-automated VCDR measurements and 
ophthalmoscopy are shown in Table 6. Mean VCDR, its asymmetry between 
both eyes, and mean minimal rim width were not significantly different in 
independently living subjects and those in nursing homes (data not shown). A 
VCDR ;, 0.7 was for both semi-antomated and ophthalmoscopic VCDR 
assessments statistically abnormal (above 97.5'" percentile). Asymmetry in 
VCDR between both eyes of 0.26 or more was statistically abnormal for semi-
automated measurements; for ophthalmoscopic VCDR estimates this cut-off 
point (97.5Ih percentile) was 0.20 or higher. A minimal rim width of 0.07 or less 
using semi-automated measurements was statistically abnormal. 
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Table 7. Prevalellce a/glaucomatous visllaljield defects' 
Age (years) Men (%) 'Vol1lcn (%) Total (%) 
55-59 2/474 (0.4) 0/668 (0.0) 211142 (0.2) 
60-64 5/602 (0.8) 4/763 (0.5) 911365 (0.7) 
65-69 111579 (1.9) 7/658 (1.1) 1811237 (1.5) 
70-74 13/424 (3.1) 11/628 (1.8) 2411052 (2.3) 
75-79 8/282 (2.8) 7/444 (1.6) 151726 (2.1 ) 
80+ 101149 (6.7) 9/312 (2.9) 19/461 (4.1) 
Total 49/2510 (2.0) 38/3473 (1.1) 87/5983 (1.5) 
. For criteria see measurements section. 
The prevalence of glaucomatous visual field defects is shown in Table 7. 
The overall prevalence of glaucomatous visual field defects was 1.5%. Men had 
a two times higher risk of visual field defects compared to women (Odds ratio 
2_0,95% CI 1.3,3.1). The risk offield defects increased with age by 10% pel' 
year (Odds ratio 1.10,95% CI 1.07, 1.12). 
Although we did not include rop in our OAG criteria, we give in Table 8 
the different prevalence figures of OAG, using various cut-off points for VCDR, 
with 01' without elevated rop for comparison with other studies. Also, 
sensitivity and specificity values are shown for optic disc parameters and IOP 
for the presence of a glaucomatous visual field defect. Figure 2 shows the 
prevalence figures of OAG by age in our study, when using OAG definitions 
from other large population-based studies. This resulted in prevalence figures 
varying between 0.0 and 1.4% in the youngest age-categories to prevalence 
figures between 0.9 and 5.9% in the oldest age-group. 
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Table 8. Prevalence of Opel/-Angle Glallcoma according to different cllt-off points 
fo/' VCDR and lOP. 
Criteria for OAG Prevalence ofOAG (%) Sensitivity' (%) Specificity" (%) 
Glaucomatous visual field defect in combination with: 
VCDR,O.4 l.l 87.7 24.3 
VCDR,0.5 1.0 76.9 46.4 
VCDR,0.6 0.7 53.8 75.3 
VCDR,0.7 0.5 36.9 95.5 
VCDR,0.8 0.2 13.8 99.8 
Glaucomatous visual (ield defect in combination with: 
VCDR:e-. 0.4 or lOP> 21 mmHgf 1.2 90.7 23.5 
VCDR, 0.5 01' lOP> 21 mmHg! 1.0 81.3 44.4 
VCDR, 0.6 01' lOP> 21 mmHg! 0.8 62.7 71.9 
VCDR, 0.7 01' lOP > 21 mmHg! 0.6 52.0 90.9 
VCDR , 0.8 01' lOP> 21 mmlIg! 0.5 42.7 94.7 
Glaucomatous visual field defect in combination with: 
VCDR, 0.4 and lOP> 21mmlIg! 0.4 24.7 96.9 
VCDR, 0.5 and lOP> 21 IImllIg! 0.4 24.7 97.7 
VCDR ~ 0.6 and lOP> 21 mmHgf 0.4 23.4 98.7 
VCDR ~ 0.7 and lOP> 21 mmHgf 0.3 19.5 99.6 
VCDR, 0.8 alld lOP> 21 lIulIHg! 0.1 9.1 99.9 
Glaucomatous visual field defect in combination with: 
VCDR ~ 0.7, or asymmetry in VCDR ~ 0.3, 
or minimal rim width < 0.10 0.6 70.3 76.9 
* Sensitivity and specificity values of optic disc andlor lOP criteria described in the left column with regard to the 
presence of a glaucomatous visual field defect. 
f or JOP lowering treatment. 
Using oUt' OAG criteria, 37 of the independently living subjects, had definite 
OAG (0.6%, 95% CI 0.4, 0.8%; Table 9). The risk of OAG increased with 8% 
per year of age (Odds ratio 1.08, 95% CI 1.04, 1.13). Men had a higher risk 
compared to women (Odds ratio 2.3, 95% CI 1.2, 4.5). In those subjects where 
semi-automated measurements of the optic disc were not available, 
ophthalmoscopic data were used to diagnose OAG. Using the ophthalmoscopic 
31 
Chapter 2 
0-
e'S 
'" u c 
.2 
" e 
0-
6 
/ 
Criteria according to: 
/ 
5 
- -
Baltimore Eya Survey 
............. Blue Mountains Eye Study ,/ 
Rotterdam Study / 
---- -
Beaver Dam Eye Study 
-. 
-
. - Framingham Study / 
4 , 
/ 
3 / 
-
-,/ 
/ 
2 ./ , /" / ............ I- - - , , -
L 
-
-
." .......... 
~--~'.' .'--.:~ :'-:.-. ,.,. - ................ 
.. .... . .. . ... .. ....................................... 
. , v ,"!A'I..~·::·":. ::::,:, .................. , ....... ,. 
, , o 
55-59 
. • 
60·64 65.69 70·74 75·79 80+ 
age 
Figure 2. Variatioll ill prevalellce figures of GAG in the Rol/erdam Study depending 
on various definitions of GAG as used by other population-based studies. 
optic disc data, 19 (0.3%, 95% CI 0.2, 0.4%) additional cases were diagnosed. 
This yields a total prevalence of OAG of 0.9% (n=56; 95% CI 0.6, 1.1%). Due 
to our century-long affinity with lOP we also indicated at the bottom of Table 9 
the lOP status of these cases. Combining the semi-automated and the 
ophthalmoscopic OAG cases did not significantly change the risk estimates for 
age and gender. Probable OAG, defined as the presence of a glaucomatous 
visual field defect without optic disc abnormalities, was present in 31 subjects 
(0.5%, 95% CI 0.3, 0.7%). Probable OAG, defined as an optic disc suspect for 
OAG without visual field abnormalities was present in 743 subjects (11.8%, 
95% CI 11.0, 12.6%). Combined, this yields a prevalence of 12.3% (95% CI 
11.5,13.1%) for probable OAG. 
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Of the 56 diagnosed OAG cases, 23 subjects (41.1%, 95% CI 25.1, 48.1%) 
received IOP lowering treatment. On the other hand, only 23 of 244 subjects 
(9.4 %, 95% CI 6.8, 14.6%) with lOP lowering treatment, had OAG according 
to our criteria. The sensitivity of elevated lOP (> 21 mmHg) for OAG was 
97.3%; the specificity was 15.2%. The predictive value of an IOP > 21 mmHg 
was 99.5%; the predictive valne of an lOP ~ 21 mmHg was only 3.0%. 
Glaucomatous visual field defects were present in 8.6% of all subjects with 
a VCDR ;0- 0.7. This prevalence increased to 38% in subjects with a VCDR ;0-
0.8, and to 60% in subjects with a VCDR ~ 0.9. 
In nursing homes no visual field testing was performed. Only probable 
glaucoma could be diagnosed based on optic disc appearance. The prevalence 
of probable OAG was comparable with prevalence figures of probable OAG in 
the independently living subjects in the same age-categories. 
DISCUSSION 
In this study all parameters leading to an OAG diagnosis have been evaluated 
separately in a masked way, and criteria for OAG were strictly based on 
statistically accepted rules. Hithelio, studies used information on lOP or VCDR 
to grade visual field defects and OAG. Even though those studies used explicit 
diagnostic criteria, this may have introduced assessment bias. 
In this population we found an overall prevalence of OAG of 0.9% in the 
independently living subjects. The prevalence increased with age and was more 
than two times higher in men than in women. Of all the OAG cases 59% had 
not been identified before. By estimating prevalence of OAG using criteria of 
other studies, we demonstrated that the influence of diagnostic criteria on the 
prevalence is large, and can vary ten-fold. 
Our overall prevalence of OAG of 0.9%, is comparable with prevalence 
figures of the Framingham Study'O (1.2%), The Baltimore Eye Survey' (1.1 %), 
and with the prevalence found among the white subjects of the Barbados Eye 
Study" (0.8%). The Beaver Dam Eye Study and the Blue Mountains Eye Study 
on the other hand found a higher overall prevalence of 2.1%8 and 3.0%11 
respectively. 
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Table 9. Prevalence oJOpen-Angle Glaucoma (OAG) - The Rotterdam Study, 1990-1993 
Definite Ophthal. Probable OAG Definite Opbthal· Probable OAG 
I 
category Men OAG· moscopiCt VFD' Optic discli Women OAG· moscopict VFD' Optic discli (years) (%) (%) cas~(o/~ ~.) (%t (N) (%) cases (%) (%) (%) , 
-
, 
Independently living subjects. 
55·59 483 I (0.2) o (0.0) 1 (0.2) 60 (12.4) 681 o (0.0) 0(0.0) 0(0.0) 66 (9.7) 
60·64 616 4 (0.6) 0(0.0) 1 (0.2) 68 (11.0) 785 1 (0.1) o (0.0) 3 (0.4) 93 (11.8) 
65-69 595 3 (0.5) 2 (0.3) 6 (1.0) 81 (13.6) 686 3 (0.4) 3 (0.4) 1 (0.1) 90 (13.1) 
70·74 452 4 (0.9) 5 (l.l) 4 (0.9) 35 (7.7) 656 4 (0.6) 4 (0.6) 3 (0.5) 81 (12.3) 
75·79 315 6 (1.9) o (0.0) 2 (0.6) 35(11.1) 483 3 (0.6) 1 (0.2) 3 (0.6) 56 (11.6) 
SO+ 166 4 (2.4) 3 (1.8) 3 (1.8) 36 (21.7) 375 4 (l.l) 1 (0.3) 4 (1.1) 42 (11.2) 
Subtotal 2627 22 (O.S) 10 (0.4) 17 (0.6) 315 (12.0) 3666 15 (0.4) 9 (0.2) 14 (0.4) 42S (11.7) 
Nursin!! home SUbjects . 
-
. 
55·59 0 o (0.0) 0 o (0.0) 
60-64 0 0(0.0) 1 0(0.0) 
65-69 4 0(0.0) 4 0(0.0) 
70·74 4 1 (25.0) 8 o (0.0) 
75·79 18 2 (11.1) 43 6 (14.0) 
80+ 96 19 (19.8) 310 47 (15.2) 
Subtotal 122 22 (IS.0) 366 53 (14.5) 
Total number of definite and probable OAG cases in independently living subjects and nursing borne subjects. 
Men 
Definite Ophthal· Probable OAG 
Women 
Definite Ophthal- Probable OAG 
category OAG· moscopict VFD' Optic disc§ OAG· moscopict VFD' Optic disc§ (years) (1'1) (%) cases (%) (%) (%) (N) (%) cases (%) (%) (%) 
TOTAL 2749 22 (0.8) 10 (0.4) 17 (0.6) I 337 (12.3) 4032 15 (0.4) 9 (0.2) 14 (0.3) I 481 (11.9) 
lOP status in definite and probable OAG cases. 
lOP Men 
Definite Ophth~l- Probable OAG Women Definite Ophthal- Probable OAG I OAG· moscoplCt VFD' Optic disc§- OAG' moscopict VFD' Optic disc§ 
status (%) cases (%) (%) (%) (%) cases (%,) (%) (%) 
Normal' 10 (45.5) 5 (50.0) II (5.9) 296 (87.8) 8 (53.3) 5 (55.6) 13 (92.8) 440 (91.5) 
Elevated 3 (13.6) 0(0.0) 3 (17.6) 6 (1.8) 1(6.7) 1(11.1) 1(7.1) 19 (4.0) 
• 
Treated 9 (40.9) 5 (50.0) 3 (17.6) 35 (10.4) 6 (40.0) 3 (33.3) o (0.0) 22 (4.6) 
- - -
. 
---------- -
Definite OAG was defined as presence ofa glaucomatous visual field defect in combination with a VCDR <:: 0.7. or asymmetry <:: 0.3 in VeDR, or a minimal rim:'!: 0.10 with 
semi-automated measurements. 
Ophthalmoscopic cases were defmed as subjects with a visual field defect, missing semi-automated measurements. but an ophthalmoscopic VCDR <:: 0.7 or asymmetry <:: 0.2 in 
VCDR 
l Probable OAG, defined as the presence of a glaucomatous visual field defect (VFD) without optic disc abnormalities suspect for OAG. 
~ Probable OAG, defmed as an optic disc suspect for OAG, but without glaucomatous visual field defect (VFD). 
1 Normal rop was defined as an rop ~ 21 mmHg without treatment 
fl Elevated rop was defmed as an lOP> 21 mmHg without treatment. 
•• Treated = lOP lowering treatment. 
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Prevalence differences may reflect either real geographic differences in 
prevalence, or differences in measurement methods, subjective interpretation of 
these measurements, diagnostic criteria, or a combination of these. Since other 
sources of differences cannot be ruled out, conclusions on geographic 
differences are not justifiable. An interesting finding is that most studies report 
similar prevalences despite significant differences in methods and criteria. 
Differences in measurement methods mainly involve the use of suprathreshold 
or full-threshold peri metric techniques and the assessment of optic disc 
characteristics. Studies have shown that suprathreshold perimetry identifies 
about 2/3 of all cases identified by full-threshold perimetry." Taking this into 
account, our prevalence would be about 1.4% if we had used full-threshold 
perimetry. Comparison with the Blue Mountains Eye Study, in which full-
threshold perimetry actually was used, would in that case still result in a two-
fold prevalence difference. This could indicate that geographic differences or 
differences in assessment of optic disc characteristics may be a major 
determinant of prevalence differences. 
Our study differs from other large population-based studies, because optic 
nerve damage was mainly assessed by semi-automated optic disc measurements 
(enlargement of VCDR, narrow neuroretinal rim, asymmetry in cupping 
between both eyes). These measurements were unbiased by knowledge of visual 
field status or IOP of the subjects. Furthermore, the semi-automated system 
used strict criteria for defining the cup margins, based only on topographic data, 
therefore reducing variation due to different observers; that makes it also 
particularly interesting for follow-up studies. 18 We found a higher mean VCDR 
on semi-automated measurements (0.49) compared to other studies using other 
methods for examining the optic disc (mean VCDR 0.28', 0.310 using 
ophthalmoscopy by several examiners, 0.368 and 0.43 11 by grading of 
photographs). As a result, also the prevalence of an enlarged VCDR was higher 
in our study compared to other studies (VCDR;, 0.4: 77.2% in our study, 
compared to 27.1 %', 37.0%8). However, our prevalence of a VCDR ;, 0.7 was 
only slightly different from the findings of the Blue Mountain Eye Study 
(5.0%)11. Also, asymmelty in VCDR between both eyes was more prevalent in 
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our study, compared to findings of other studies (4.6% asymmetty;, 0.2", 0.7% 
asymmetry;, 0.3 11 ). Differences in technique and criteria for defining the cup 
margins play an impOllant role in the findings of the studies. Even interpretation 
of photographs is subject to interobserver variation." 
The visual field screening and grading procedure in our study resulted in a 
prevalence of 1.5% of visual field defects compatible with glaucoma. This is 
comparable with the findings of the Framingham Study (1.4%, enlargement of 
blind spot excluded)", but lower than that found in Australia (3.1 %)." The Blue 
Mountains Eye Study used, after screening, Humpln'ey full threshold perimetry 
(C30-2), which is more sensitive compared to kinetic Goldma1l11 perimetry'., 
but also creates more false-positive results, especially in the elderly. This could 
explain the higher prevalence of visual field defects. Also screening algorithms 
differ between studies. The Blue Mountain Eye Study screened once with the 
same Humphrey suprathreshold test as ours followed by full-threshold 
perimetty, and some studies only performed perimetry in a selected subset of 
participants, while other studies performed perimetry in all subjects. Full 
threshold perimetry is nowadays considered to be the gold standard for visual 
field examination, but especially in older subjects may create more false 
positive errors compared to Goldmann perimetty. 
The rap is one of the three entities of the 'classical' OAG diagnosis. rn the 
past, rap measurement was the most important feature of the screening for 
glaucoma'5, and several recent studies have used elevated rap as a criterion for 
glaucoma.s. I' However, nowadays most studies see elevated rap more as a risk 
factor for glaucoma, and not as compulsory for the diagnosis." 9. II The mean 
rap of 14.5 mmHg found in our study was slightly lower than the mean rap 
found in other studies.4, 5. 8. II. 26 Presumably, this can be explained by an rap 
lowering effect of the glucose solution which was given to the participants. We 
found a significantly lower rap in subjects who had undergone the glucose 
tolerance test compared to subjects who had not undergone this (mostly subjects 
with diabetes mellitus and subjects which had undergone a gastrectomy). 
Consequently, the prevalence of elevated rap (2.8%) was lower than that in 
other studies (6.9%", 8.6%4) When we adjusted for the rap lowering effect of 
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the glucose solution the prevalence of elevated lOP increased to 8J%. Several 
studies found a positive relation between age and lOP"', which they found most 
apparent in the lower age-categories. We could not find a significant relation 
between age and lOP, nor did we find a significant difference in lOP between 
men and women, as was suggested by some studies'" 26 Other large population-
based studies also failed to find a difference in lOP between men and women."B 
The relation between OAG and gender is still controversial. In Framingham' 
and Barbados9 a higher prevalence of OAG was found in men, as we did in the 
present study. However, in the Blue Mountain Eye Study a (borderline 
significant) higher risk of glaucoma was found for women (Odds ratio 1.55)11, 
and in Baltimore' and Beaver Dams no difference was found. It might be that 
differences in age- and gender distributions in the different studies are the cause 
of the contrasting findings. 
In nursing homes inhabitants we were not able to perform reliable visual 
field testing, due to many physical and mental disabilities. Data on lOP and 
VCDR were not significantly different from independently living subjects 
(adjusted for age and gender), suggesting that there were not many differences 
in prevalence of OAG in comparable age-categories. However, the response in 
the nursing homes was low, especially in the older subjects, increasing the risk 
of selection bias. The age distribution of subjects in nursing homes is very 
different from the age distribution of the independently living subjects. This 
could be a cause for a higher overall prevalence of OAG in nursing homes 
compared to independently living subjects, as was reported earlier.21 
In this study, OAG was defined as a glaucomatous visual field defect with 
kinetic Goldmann perimetry, in combination with optic disc abnormalities 
suspect for glaucoma. These optic disc abnormalities were defined as a VCDR 
z 0.7, or asymmetry z OJ between both eyes, or a minimal rim width < 0.10 
using semi-automated measurements, or when semi-automated measurements 
were not available, an ophthalmoscopic estimated VCDR z 0.7 or asymmetry z 
0.2 between both eyes. Cut-off points were all strictly based on statistical 
grounds (97.5th percentiles). We would like to propose this definition as a 
commencement for an international definition for OAG in epidemiologic 
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research. FUliher discussion 011 screening algorithms and methods is needed. 
In conclusion, the overall prevalence of OAG in the Rotterdam Study was 
0.9%, which is comparable to findings of other population-based studies on 
Caucasians. Men had a higher risk of having OAG compared to women. There 
was a significant increase in prevalence of OAG with increasing age. The 
overall prevalence of OAG varies strongly with different criteria and screening 
algorithms. Standardizing diagnostic procedures and definitions is needed to 
improve future (epidemiologic) glaucoma research. 
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VISUAL FIELD Loss IN A GENERAL POPULATION 
PREVALENCES, CAUSES AND ASSOCIATIONS 
WITH DAILY LIFE FUNCTIONING 
ABSTRACT 
Objective: To determine the prevalence and causes of central visual field loss 
(VFL) in the elderly. To determine the association between VFL and indicators of 
impairment in daily life. 
Design: Prevalences and causes were measured cross-sectionally in a population-
based COh011 study. Indicators of impairment were measured both cross-sectionally 
and prospectively after a 2 year follow-up. 
Participants: All community-dwelling inhabitants, aged 55 years or over, were 
invited to participate, 6250 (68%) of 9161 eligible residents took pat1 in 
ophthalmological examinations. 
Methods: Visual fields of both eyes were examined using a suprathreshold test 
designed for the central part of the visual field. The eye was re-tested when a 
defect was present in at least three adjacent points and Goldmann perimetry was 
performed if the defect persisted. Causes of defects were determined using eye and 
neurological examination data and history data fi'om ophthalmologists and general 
practitioners. Interview data and data from medical records on disability in daily 
life, reading, use of walking aids, incident falling and incident fractures were used 
to assess impairment. 
Results: The overall prevalence of defects was 5.6%, ranging from 3.0% in 55-64 
year olds to 17.0% in 85+ year olds. Glaucoma was the leading cause at all ages. 
Before age 75 years, other optic disc diseases and stroke were the second and third 
most common cause. After this age, age-related macular degeneration and retinal 
vascular occlusive disease ranked second and third. Independent from having low 
vision, VFL was associated with disability, with diminished enjoyment of reading 
and watching TV, and with a higher risk of falling in the 2 years after the eye 
exam. Risk of hip fracture or any other fracture was, however, not significantly 
increased. Of all subjects with VFL, 28% was unaware of the defect and had never 
visited an ophthalmologist except for glasses. 
Conclusions: VFL is as common as visual impairment and associated with serious 
impaired functioning in daily life in community dwelling elderly. Glaucoma is the 
leading cause'at all ages. Other causes, some of which are pat11y preventable, vary 
by age. 
Visllal Field Loss; Prevalences, Callses and Associations 
The decline of visual function with age is well known and a source of major 
concern in the elderly. Besides visual acuity, visual function also largely depends 
on the quality of the visual field.' The prevalence of visual acuity loss in elderly 
has been well studied,' but data on the prevalence of visual field loss (VFL) are 
sparse. An Australian study found VFL to be present in 17% of all eyes in adults 
aged 40 and over.3 Among elderly driving licence applicants, 13% had VFL.4 
However, these studies did not have the oppOitunity to investigate the causes of 
VFL. To plan research and to develop strategies for diagnosis, prevention and 
therapy of disabling eye disease, accurate data on causes ofVFL are needed. 
The presence ofVFL may threaten the ability of community-dwelling elderly 
to maintain their independence. Impairment in daily life is well known to be 
associated with decreased visual acuity,' but recent studies indicated that VFL may 
also be causing impairment to a considerable extent. Field loss was shown to be 
associated with frequent falling and decreased quality of life.''? Persons with VFL 
perceived more difficulty in daily activities even in the presence of good visual 
acuity.' However, these studies were cross-sectional and were clinic-based,,8 or did 
not have the opportunity to exclude the influence oflow visual acuity.' We set out 
to determine the prevalence and causes of visual field defects and their effects on 
daily life functioning among community-dwelling Caucasians, aged 55 years and 
over, in a large population-based study in Rotterdam, The Netherlands. 
MATERIAL AND METHODS 
This study was conducted as part of The Rotterdam Study, a prospective 
population-based study of determinants and prognosis of chronic diseases in 
subjects aged 55 years and over living in a city district of Rotterdam: The study 
has been approved by the Medical Ethics Committee of Erasmus University 
Medical School and was conducted in accordance with the Declaration of Helsinki. 
From 1990 to 1993, baseline investigations were conducted. These consisted of a 
home interview and an eye and neurological examination at the research center. 
From 1993 to 1995, patticipants were re-intetviewed at home after a mean interval 
of three years since their last visit. The present study is confined to community-
dwelling subjects. 
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Eye examination. 
The extensive eye examination has been described before.' It included indirect 
ophthalmoscopy of both the central and peripheral retina, photography of the 
macular area (35 0 field), stereo photography of the optic disc (20 0 field), and 
visual field testing. 
The visual field of each eye was screened with a 52-point suprathreshold test, 
that covered the central part of the field with a 24 degree radius. The test was 
modified from a standard 76-points screening test (Humphrey Field Analyzer, 
Zeiss, Oberkochen, Germany). This test was repeated if defects were present. A 
defect was defined as not having responded to the light stimulus in at least three 
contiguous test points or four contiguous points ifthe scotoma included the blind 
spot. If fixation-losses, false-negative or false-positive results exceeded 20%, 
testing was halted and the palticipant was reinstructed before undertaking a new 
test. If the percentage of false-positive or false-negative results or fixation losses 
exceeded 33%, the test was considered to be unreliable. If defects were present on 
the second suprathreshold test in at least one eye, Goldmann kinetic perimetry was 
performed by an experienced perimetrist on both eyes according to a standard 
protocol. '0 
All Goldmann fields were independently graded by six researchers who had no 
information other than refi'active error data. Each field was graded on the presence 
or absence ofVFL and on the type of defect if present. Three graders were senior 
ophthalmologists, two were ophthalmologic residents and one grader was an 
experienced perimetrist. Ifthere was disagreement in the grading of a Goldmann 
visual field, consensus was reached. Visual field loss was not considered to be 
present in case of a symmetrically enlarged blind spot. 
Determination of causes of VFL. 
For all eyes with VFL on Goldmann perimetry, a senior ophthalmologist 
(PTVMdJ) determined whether and where field loss was to be expected based on 
the presence and localization of retinal abnormalities using macular and optic disc 
centered transparencies. This was done without knowledge of the outcome of 
Goldmann perimetry. Control transparencies of subjects without defects on 
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Goldmann perimetry were mixed with the other transparencies, to prevent bias. If 
VFL did not correspond with a funduscopic lesion, the cause of VFL was 
determined using data from the ophthalmological examination, home interview, 
neurological assessment, and additionally obtained information from medical 
records of general practitioners and ophthalmologists. Sometimes multiple, related 
causes were present, e.g. diabetes-related proliferative retinopathy requiring laser 
coagulation. In these instances, the initiating process was recorded as the primary 
cause (in casu diabetes). Definite open-angle glaucoma, defined as VFL with 
corresponding optic nerve head damage, and possible open-angle' glaucoma, 
defined as glaucomatous VFL in the absence of any other neurologic or 
ophthalmologic cause, were lumped. Age-related macular degeneration was 
defined as geographic atrophy or neovascular macular degeneration according to 
international standards. I I Optic nerve head related disease was defined as all 
abnormalities or diseases primarily affecting the prechiasmal optic nerve excluding 
open-angle glaucoma. This included tilted disc, myelinated nerve fibers, secondary 
glaucoma, ischemic optic neuropathy and Leber's optic nerve atrophy. Peripapillmy 
atrophy was also included in this disease group. Retinal vascular occlusive disease 
comprised central or branch arterial and venous occlusions. Because medical 
records often did not specify whether occlusion was arterial or venous in nature, 
they were lumped. Visual field loss due to stroke was diagnosed if the VFL was 
consistent with the neurological examination (see below) or if subjects reported 
that a physician had diagnosed stroke in the past. In keeping with World Health 
Organization criteria, low vision was defined as a best corrected visual acuity of 
less than 0.3 (20/60) in the better eye. 12 
Other measllrements. 
Subjects were neurologically assessed by a single team of physicians. In order to 
detect signs of stroke, the assessment comprised neurological history taking, 
testing of the glabellar, brachial tendon and gastrocnemius tendon reflexes, motor 
tone of the limbs, Romberg's cerebellar test and testing for hemiparesis. 
At the home interview, responses were recorded for the questions" Have you 
ever visited an ophthalmologist because of trauma, diabetes, glaucoma or 
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otherwise?", "Did you ever experience a sudden loss in visual ability, which lasted 
less than 24 hours?", and "If you ever had eye surgery, did it involve the retina, the 
cornea 01' laser treatment?". 
Disability in daily activities was measured in eight components (ie., dressing, 
rising, reaching, hygiene, eating, walking, grip, and activity) as described 
previously.13 Moderate disability was present when snbjects perceived difficulties 
in at least four of the eight components. In addition, subjects were asked "Are you 
homebonnd because of health problems?", "Do yon use a walking aid?", "Do you 
fall more than once a month?" and "Have you had a broken bone in the past five 
years?". At the second interview, on average three years after the baseline 
examination, subjects were asked "Do you enjoy reading a book or watching 
television?", "Did you fall more than four times in the last two years?" and "If you 
have fallen, were any bones fractured?". If subjects had moved into a nursing 
home, they were also interviewed. Non-vertebral fractures occurring after the 
baseline examinations, up to March 1st, 1996, were repOlted by general practioners 
in the study district and verified by staff physicians using medical records and 
hospital discharge records. Mean follow-up period was 3.8 years and complete 
follow-up was available for 83% (5186/6250 subjects). 
Statistical analysis. 
All ophthalmologically examined subjects were included in the analyses unless 
they met one or more of the following exclusion criteria: (I) no visual field testing 
in either eye because of physical 01' mental disabilities or refusal; (2) missing 
ophthalmoscopic data. Characteristics of included subjects, excluded subjects and 
subjects refusing the eye exam were compared using multiple logistic regression 
analysis for categorical variables with adjustment for age and gender. For 
continuous variables, means and differences across the three groups were 
calculated using analysis of covariance with adjustment for age and gender. 
Prevalences are repOlted as percentages with their 95% confidence interval (CI). 
Associations of VFL with indicators of impairment in daily life measured at the 
second visit, were analyzed using logistic regression and adjusted for age and 
gender. Associations of VFL with the occurrence of fractures after the baseline 
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examinations were analyzed using Cox's proportional hazards model with 
adjustment for age, gender and presence of moderate disability. P-values lower or 
equal to 0.05 were considered to be statistically significant. 
RESULTS 
Of all 9161 eligible, community-dwelling subjects, 7086 (77%) participated and 
they were extensively interviewed at their homes. Palticipation among younger 
subjects was over 80%, declined with age, but was not sex-dependent (Figure I). 
Of the 7086 pmticipating subjects, 6322 underwent an ophthalmological 
examination at the research center. Ultimately, 6250 subjects, 68% of the eligible 
population, remained included after applying the exclusion criteria. General 
characteristics of the included and excluded subjects and participants who refused 
the eye exam, are presented in Table I. Compared to included subjects, refusing 
subjects were significantly older, were more often homebound due to health. 
problems and had visited the ophthalmologist more often because of diabetes, but 
not because of glaucoma. 
1161 1162 532 64 1552 1510 913 192 
(1422) (1427) (753) (124) (1819) (1916) (1332) (368) 
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Figure 1. Age and gender distribution ofpal'licipatlilg subjects who all consented to at least 
extensive interviewing (number all top of bars). Participants call/prise subjects who refused the 
eye exam (white bars), subjects with an eye exam that were excluded ajlel1vards (black bars) 
alld included subjects (shaded bars). NUll/bel's betweell brackets are the nUll/bel's of eligibles. 
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Table 1. General and Clinical Characteristics 0/ Subjects. 
Included Excluded Subjects refusing eye 
Subjects Subjects exam, but consenting 
to interview (1l~6250) (IF72) (n~764) 
Mean age, yrs (unadjusted) 68 75j 74j 
""--" 
Women, % (unadjusted) 58 
Homebound for health reasons, % 29 
Moderately disabled, % 259 
Visual acuity best eye <0.5, % 23 
Visited ophthalmologist for other reason than 
408 prescription of glasses, % 
Visited ophthalmologist because of glaucoma, % 42 
Visited ophthalmologist because of diabetes, % 21 
Stroke diagnosed by physician, % 33 
.. Values are means, adjusted for age and gender, unless otherwise indicated. 
t P<O.005 for the difference with included subjects 
63 65j 
9"7j 29.3j 
82.9j 38.6j 
35 not measured 
321 382 
"---
OJ 32 
21 4.5j 
29 38 
Table 2. Prevalence o/Central Visual Field Loss by Age and Gender. 
Visual Field Loss in at least One Eye 
Age (years) Subjects (N) Prevalence n (%) 
"--"--- "---"" 
Men __ _ 
55·64 1095 39 (3.6) 
65·74 
--""--- ----"=-~- 1037 73 (7.0) 
75·84 440 52 (11.8) 
-"--"---
85+ 39 9 (23.1) 
All men 2611 173 (6.6) 
""---" 
'VOI."ne:::n,--_ 
"---" 
55"64 1460 38 (2.6) 
"---" 
65·74 1334 60 (4.5) 
75·84 738 57 (7.7) 
85+ 107 19 (17.8) 
All women 3639 174 (4.8) 
Total 6250 347 (5.6) 
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We identified 347 subjects, 5.6% (95% CI 5.0,6.1) of the included subjects, 
who had VFL in at least one eye. Table 2 gives the prevalence of VFL by age and 
gender. The prevalence ofVFL rose sharply from 3% (77/2555) in those aged 55-
64 years to 19% (281146) in those aged 85 years and over. Women had less often 
VFL after adjustment for age (OR 0.63, 95% CI 0.38-0.79). Bilateral VFL was 
present in 1.7% (109/6250). Concentric constriction of the visual field to the 
central 10 degrees was present in four subjects. 
20,----------------------, 20,-----------------------
Women 
16 +-------------------------1 
prevalence 
(%) 12+--------------------f--~ 
55-64 65·74 75-84 85+ 55·64 65-74 75·84 85+ 
age (yrs) age (yrs) 
Figure 2. Prevalences ("/0) of central visual jield loss by cause and age-group in men (leji) 
and women (right). Lines denote primQl)' glaucoma (---), age-related macular 
degeneration (----), retinal vascular occlusive disease ( ... ), stroke ( -.-.-.-) and optic 
nerve disease other than glaucoma ("-"-"). Ranking order of diseases may differfi'om 
that in Table 3, because prevalences pertain to individuals and not to eyes. 
In most cases, the cause ofVFL was only present in one eye or was the same 
for both eyes. However, in 16% (56/347) of cases, fellow eyes differed in cause. 
Therefore, prevalences of various causes are most clearly represented as 
percentages of eyes rather than percentages of subjects. Table 3 gives the causes 
ofVFL by age category. At all ages, open-angle glaucoma was the leading cause 
ofVFL. In subjects aged 55 to 74 years, other optic nerve head diseases and stroke 
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ranked second and third as most frequent cause. In subjects aged over 75 years, 
AMD and retinal vascular occlusive disease ranked second and third. The cause 
of VFL in 23 eyes could not be determined, because records could not be traced 
or because causes were ambiguously recorded. Using macular and optic disc 
transparencies and ophthalmoscopic data, definite open-angle glaucoma, AMD, 
myopic macular changes, diabetic retinopathy and retinal detachment could be 
excluded as cause. 
Table 3. Causes of Visual Field Loss ill 435 Eyes of 347 Subjects by Age. 
55-64 yrs 65-74 yrs 75-84 lTS 85+ yrs All ages 
Cause Number of eyes FA) 
OpenaAngle Glaucoma 12 (14) 61 (36) 35 (24) II (31) 119(27) 
Age~related Macular Degeneration 4 (5) 9 (5) 32 (15) 15 (43) 60(/4) 
Retinal Vascular Occlusive Disease 6 (7) 19 (//) 9(6} 6 (/7) 40 (9) 
Optic Nerve Head Disease 
16 (18) 20 (12) 6(4) 0(0) 42(10) 
other than open-angle glaucoma 
Stroke 9 (9) 12 (7) 10(6) 1(3) 30 (7) 
Retinal Detachment 6 (7) 10 (6) 11(6) 0(0) 24 (6) 
Myopia 10 (JI) 5 (3) 7 (5) o (O) 22 (5) 
Diabetic retinopathy 4 (5) 3 (2) 10(5} o (O) 14 (3) 
Ocular Trauma 4 (5) 3 (2) 4(2} o (O) 10 (2) 
Rare causes (chorioretinitis, eye 
II (12) 16 (IO) II(S) I (3) 39 (9) 
prosthesis, congenital abnonnalities)' 
Combined mechanisms' I (I) I (I) 9 (6) I (3) 12 (3) 
Unknown 5 (6) 9 (5) 9 (6) 0(0) 23 (5) 
All causes 88 (lOO) 168 144 (IOO) 35 (IOO) 435 (IOO) 
. Rare causes included congenital cataracts (2 eyes), melanoma and otlier tumors (2 eyes), radiation optic neuropathy 
(l eye), choroidal infarct (J eye), retinitis pigmclliosa (3 eyes) and meningitis (2 eyes). 
f Combined mechanisms included secondary glaucoma and venous occlusion (1 eye), open-angle glaucoma and venous 
occlusion (2 eyes), open angle glaucoma and diabetic retinopathy (l eye), secondary angle-closure glaucoma with 
SjOgrens syndrome (1 eye), AMD and peripheral retinal degeneration (1 eye), retinal detachment and chorioretinitis 
(1 eye), chorioretinis and optic atrophy (I eye), AMD and POAG (2 eyes), and AMD and venous occlusion (1 eye). 
Figure 2 shows the absolute prevalences of the five major causes by gender. 
For AMD, retinal vascular occlusive disease, stroke, optic nerve head disease, 
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statistically significant gender differences in prevalence were absent. Glaucoma, 
however, was less frequent in women (odds ratio 0.52, 95% CI 0.38-0.81). 
Bilateral VFL due to a single cause, was in 28% (30/1 09) of cases caused by 
primary glaucoma and in 21% (23/109) by AMD. Interestingly, stroke was 
diagnosed in 276 subjects, while only 4.7% of these had VFL. 
Of those subjects with VFL, 28% indicated that they had never visited an 
ophthalmologist. Compared to those subjects who were aware of their VFL, 
unaware subjects were not different regarding age, gender, education and income. 
However, unaware subjects less often had low visual acuity (OR 0.22, 95% CI 
0.07-0.65). 
Associations of the presence of unilateral and bilateral VFL and indicators of 
impairment in daily life are shown in Table 4. To remove the contribution oflow 
vision to impairment in daily life, we excluded subjects with low vision in 
additional analyses, if applicable. Associations with indicators of impairment 
tended to be larger for bilateral VFL as compared to unilateral or absent VFL. 
Satisfaction experienced from reading books or watching TV was lower in persons 
with bilateral VFL, even ifvision was not low. Their chance offrequent falling was 
almost eight times higher compared to subjects without VFL. Nevettheless, 
incidences of wrist or hip fractures, both most commonly associated with falling, 
were not higher among subjects with bilateral VFL. Yet, subjects with unilateral 
VFL more often suffered from fall accidents in the two years after the eye 
examination and from wrist fractures during the follow-up period. 
DISCUSSION 
We have presented cause-specific prevalences ofVFL in a general population of 
community-dwelling elderly. This study demonstrated that the prevalence ofVFL 
rose sharply from 3% in 55-64 year olds to 19% in 85+ year olds. Unilateral VFL 
was present in 3.8%, bilateral VLF in 1.8%. Glaucoma was leading cause at all 
ages. Before age 75 years, other optic disc diseases and stroke were the second and 
third most common cause. After this age, age-related macular degeneration and 
retinal vascular occlusive disease ranked second and third. 
Before these findings can be accepted, some methodological issues have to be 
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addressed. Firstly, a potential limitation of this study is the restriction to non-
institutionalized sUbjects. Too often, physical or mental disabilities of 
institutionalized subjects prevented reliable field testing and the acquisition of a 
representative sample. Presumably, eye diseases associated with cardiovascular 
disease" or bilateral blindness l5 will be more frequent in these subjects. 
Associations of VFL with measures of functional impairment will therefore be 
even higher. However, the restriction to non-institutionalized elderly is necessary 
if one wants to estimate the impact ofVFL on the ability to maintain independence 
in community-dwelling elderly. 
Secondly, the generalizability of our results is a reflection of the examination 
techniques and the process of determining the cause. Small or shallow field defects 
will have remained undetected, because we required a minimum size for defects 
and used suprathreshold field testing. Nevertheless, it ensured the detection of 
clinically relevant scotomas in terms of size and depth. As for the determination 
of the cause, our cause-specific prevalences do not necessarily match the actual 
prevalence of VFL-causing lesions that can be seen on ophthalmoscopy. This is 
because we screened subjects initially on the central 48 degrees of the visual field. 
Yet, in determining disability in daily life, central VFL is clearly more relevant 
than peripheral VFL. Misdiagnosis could have occurred in those cases of 
asymptomatic retinal vascular occlusive disease that had glaucomatous VFL but 
no visible evidence on photographs or ophthalmoscopy. From a pragmatic 
viewpoint, we labeled these cases possible open-angle glaucoma, since these cases 
would be monitored for the progression of VFL. 
Thirdly, an advantage of our study is its large size. This enabled preciseI' 
estimates of the relative contribution of different causes, in patticular rare causes, 
to the prevalence. In view of the extensive neurological and ophthalmological 
examinations, the percentage of included persons, 68% of all eligibles, compares 
favorably with the 68%8 and 82%3 of other studies. Yet, as in every survey among 
elderly, non-patticipation remains a major concern. Though the number of 80+ 
years olds, 535 subjects, was considerable as compared to other studies/·8 non-
participation was highest in this age group. Therefore, the prevalence ofVFL in the 
highest age-groups may be underestimated. It cannot be excluded that non-
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participation rates for glaucoma and AMD patients are different, because of 
frequency differences in disability due to visual acuity loss. However, interview 
data on 25% of the non-examined eligible subjects, indicated that use of eye care 
was not more frequent nor was the self-reported presence of glaucoma. This 
suggests that cause-related bias was not substantial. 
Table 4. Vislllli Field Loss anti Associations with Intlicators of Impairment in Daily Life 
ill 6250 Eltlerly SlIbjects.· 
Visual Field Loss 
Absent Unilateral 
n~5903 n=238 
sllbjects subjects 
Low vision, visual acuity in better eye <0.3 0.5% 1.7%t 
Homebound for health reasons 
but no low vision 2.7% 3.6% 
Moderately disabled 4.1% 3.9% 
Moderately disabled but no low vision 4.0% 3.8% 
No enjoyment offending books and watching TV 1.9% 4% 
No enjoyment of reading books and watching TV, but 
1.8% 4.4% 
no low vision 
Use of walking aid 6% 9.1% 
Use of walking aid but no low vision 5.9% 5.8% 
Hip fracture in history 5.5% 5.1% 
Falling more than 4 times in 2~year period after eye 
0.55% 3.4%t 
examination 
Falling more than 4 times in 2~year period after eye 
0.55% 3.46%t 
examination, but no low vision 
Any fracture after eyc examination, 
4.9% 4.1% 
Reported b~ general practition:"~ 
Wrist fracture after eye examination, 
1.2% 3BYo' 
Reported by general practitioner 
llip fracture after eyc examination, 
5% 0% 
Reported by general practitioner 
• Values are means or percentages, adjusted for age, gender and moderate disability if applicable. 
t P<0.05 for the difference with subjects without field loss. 
Bilateral 
IFI09 
subjects 
22.4%t 
6.2%t 
10.6%t 
10.0%1 
7.6%f 
10.2%1 
17%1 
8.8% 
3.3% 
3.4%t 
4.33%t 
6.7% 
0% 
0% 
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To our knowledge, three surveys have addressed the frequency of VFL in 
elderly persons.3•4•8 A population-based study among subjects aged 40 years and 
over identified VFL in 17% of all right eyes and 17% of all left eyes, yielding a 
prevalence of at least 17%.3 This threefold higher prevalence as compared to our 
study, can be explained by less strict criteria for size of defects, use of threshold 
testing, and the absence of confirmatolY repeat testing. An 78-point field screening 
test with a single-intensity light stimulus among elderly drivers demonstrated that 
the prevalence of VFL in the 55-59 yr age group was 3% and rose to 13% in 65+ 
year olds.· Another study using a single-intensity stimulus found that the number 
of points missed in the central 60 degrees tripled with increasing age.' Though all 
surveys found an increasing prevalence with age, differences in measuring 
techniques and population sampling prevent a reliable comparisoll. 
Two thirds of all cases with VFL were unilateral, which points out that random 
unilateral screening would underestimate the prevalence with 33%. This is of 
practical relevance for determining the cost-effectiveness of future glaucoma 
screening programs. 
In the absence of other available population-based data, comparisons of the 
relative contribution of retinal vascular occlusive disease is only possible if one 
assumes that venous occlusions make up the largest part of retinal vascular 
occlusive disease. The overall prevalence in our study of 0.65% did not differ from 
a previous epidemiologic study on venous occlusions, that found a prevalence of 
0.54% among elderly aged 65 years and over. 16 However, our prevalence differed 
twofold from another study that observed retinal branch and central vein occlusion 
in 1.4% (55/3875)." This study based its diagnosis on ophthalmoscopy and grading 
of photographs, which may account for the difference. We found no significant sex 
difference after adjusting for age, which is in keeping with another popUlation 
based study," but conflicts with clinical series." 
Previous repOits showed that elderly progressively rely on visual feedback to 
maintain balance with increasing age, because proprioceptive feedback, 
musculoskeletal strength and often also vestibular function decline with age. 19 It 
is well known that low visual acuity is associated with a greater risk of falling, hip 
fractures and mortality among e1derly.20.21 Contrastingly, only one study has 
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focused on the association between field loss and falling: missing at least 5 points 
on supratlll:eshoid testing doubled the chance of having fallen before" Because it 
was a cross-sectional study among community-dwelling elderly, it could not be 
excluded that mUltiple fallers with field loss were more likely to be non-
paliicipants. However, this is likely since 2% of all accidental falls lead to hip 
fractures," that, in turn, lead to institutionalization in 30% or death in 15-30% of 
hip fracture cases.23 This non-participation bias may explain why subjects with 
bilateral VFL in our study less frequently had a histolY of falling and hip fractures 
than subjects without VFL. This underestimation from history data underscores the 
importance of prospective data when associations with VFL are investigated and 
explains why we prospectively found a higher risk for falling than a previous 
study" We found that both unilateral and bilateral field loss were associated with 
a sixfold increased risk of frequent falling in the two years after the eye exam. This 
association remained after subjects with impaired vision were excluded and 
adjustment for disability (e.g. walking problems) was made. This strengthens the 
possibility that also VFL and not visual acuity only, are causally related to fall risk. 
Those with bilateral VFL tended to have a higher fi'acture risk and a higher risk of 
fracture if they had a fall accident. Paradoxically, the hip fracture incidence was 
low in persons with VFL. It has been pointed out that fall characteristics, such as 
fall direction24 and outdoor mobility," may shift fracture location from hip to other 
bones. This could explain our findings, but remains speculative since the number 
of fracture cases was low. 
In conclusion, this population-based study showed that VFL was present in 
both eyes in one out of fifty elderly. Regardless of visual acuity, VFL was 
associated with absence of enjoyment of reading and watching TV, moderate 
disability in daily life activities, and, more importantly, accidental falling. 
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CHAPTER 4 
GENETIC RISK OF 
OPEN-ANGLE GLAUCOMA 
A POPULATION-BASED FAMILIAL 
AGGREGATION STUDY 
ABSTRACT 
Objective: To study familial aggregation of primary open-angle glaucoma in a 
general population, and to determine the absolute and relative risks for first-
degrees relatives. 
Methods: First degree relatives of glaucoma cases (n=48) and of controls 
(n=155) from the population-based Rotterdam Study underwent a standardized 
examination, including perimehy. 
Main outcome measures: Intraocular pressure; veliical cup-disc ratio; 
presence of glaucoma, defined as visual field defect with a cup-disc ratio ~ 0.7, 
or asymmehy ;;. 0.3 between both eyes. 
Results: Among relatives of cases, glaucoma prevalence was 10.4% among 
siblings and 1.1 % among offspring, while this was 0.7% and 0% among 
relatives of controls. Lifetime risk of elevated intraocular pressure was 42.5% in 
relatives of cases versus 6.7% in relatives of controls; of enlarged cup-disc ratio 
62.2% versus 16.6%; and of glaucoma 22.0% versus 2.3%, yielding a risk ratio 
of 9.2 (95% CI 1.2, 73.9). The population attributable risk of family history to 
glaucoma was 16.4%. 
Conclusions: In a general population, relatives of glaucoma cases have a 
strongly increased risk of glaucoma. Not intraocular pressure, but enlarged cup-
disc ratio was the earliest and most prominent feature of familial aggregation. 
Further studies are needed to disentangle the genetic components of the 
increased familial risk. 
Genetic Risk of Open-Angle Glaucoma 
The etiology of primaty open-angle glaucoma, in this paper further referred to 
as glaucoma, is as yet unknown. This disorder is the second most prevalent 
cause of incurable blindness in the elderly. I Findings from epidemiologic 
studies indicate that apart from high intraocular pressure" J and age4, ethnic 
origin', diabetes mellitus' and familial history"' 7 are associated risk factors. 
Evidence for genetic factors has been found for juvenile-onset glaucoma8-11 and 
for selected families with adult-onset glaucoma. 12-14 
As early as 1869, Von Graefe" mentioned hereditary glaucoma, and in 
1941, Duke-Elder described a type of glaucoma, which was inherited in a 
dominant manner and was called familial glaucoma. 16 Since then many studies 
have been performed in selected families, in which the familial aggregation, 
inheritance and mode of transmission of glaucoma were studied.6• 7. II. 17. IS These 
studies differed significantly in methodology and in criteria for the diagnosis 
glaucoma, resulting in different conclusions regarding the inheritance. Often 
only family history was taken into account, or a limited number of family 
members was actually ophthalmologically examined. Moreover, most studies 
were clinic-based, which opens the possibility of selection bias related to family 
history and severity of disease. Although in several studies there was evidence 
of autosomal dominant inheritance and familial aggregation 6.7, it is not clear 
whether this accounts for all glaucoma cases. 
The purpose of this study was to study whether glaucoma aggregates in 
families of a general population. We thereto selected probands from the 
population-based Rotterdam Study, and determined presence of glaucoma in 
their relatives by actual examination using a standardized protocol. We 
calculated the absolute and relative risk of glaucoma for first degree relatives, 
and estimated to what extent genetic factors attribute to the overall occurrence 
of glaucoma. 
METHODS 
Study PopUlation 
The present study was performed as a part of the Rotterdam Study, a 
prospective population-based study of determinants and prognosis of chronic 
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disabling ophthalmic, cardiovascular, neurologic, and locomotor diseases:' 19 
The study has been approved by the Medical Ethics Committee of Erasmus 
University and a written informed consent was obtained from all participants. 
At the start of our study, all known cases with glaucoma (n=48) from the 
baseline phase of the Rotterdam Stud/ were asked to participate in the family 
study (see measurement section for criteria glaucoma). In addition, a random 
sample of all pmticipants without glaucoma (no visual field defect, normal optic 
discs) was asked to serve as a control group (n=155). This group was frequency-
matched for age (in 5 years strata) and gender. Probands were contacted by 
letter and by telephone, and subsequently visited at their homes. When informed 
consent was obtained, first degree relatives were contacted for an examination. 
Eligible for this study were all first degree relatives living in the Netherlands or 
Belgium. 
Response 
The overall response among pro bands was 89.5% (188 subjects palticipated of 
the 210 eligible subjects). Among glaucoma cases, 45 of the 48 eligible 
pro bands participated (93.8%), compared to 135 of the 155 probands (87.1%) 
among controls. In siblings, the overall response was 80.1 % (209/261). Of the 
83 eligible siblings of glaucoma cases, 67 (80.7%) participated, as did 142 of 
the 178 eligible siblings of control subjects (79.8%). Overall response in 
offspring was 84.2% (288 / 342); 88 of the 95 (92.6%) eligible children of 
glaucoma cases participated, compared to 200 of the 247 (8\.0%) of controls. 
Overall response for all relatives was 82.7%. Not motivated, too old, too busy, 
and privacy reasons were the most important reasons of non-response, which 
did not differ between groups. 
Measurements 
Most family members were examined in the research center of the Rotterdam 
Study. Participants who were homebound were examined at their homes using 
portable examination equipment, including a "p0l1able" perimeter (Humphrey 
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Visual Field Analyzer II, model 750). Family members of glaucoma cases and 
of controls underwent exactly the same examinations. 
The intraocular pressure was measured three times (Goldmann applanation 
tonometer), and the median of these three consecutive measurements was 
taken.'o An intraocular pressure> 21 mmHg was considered to be an elevated 
intraocular pressure, as was intraocular pressure lowering therapy. The visual 
field was examined with the Humphrey Visual Field Analyzer, using the central 
24-2 full-threshold program. After mydriatic eyedrops, stereo fundus 
transparencies (Topcon TRC-SS2, Topcon Optical Company, Tokyo, Japan) 
were made from the optic disc, and ophthalmoscopy was performed to examine 
the optic nerve head. 
All stereoscopic optic disc transparencies were used for automated 
assessment of the optic nerve head characteristics with a digital image analyzer 
(Topcon Imagenet 2000 system). This system measured three-dimensional 
topography data based on parallax shifts between both pictures on the 
stereoscopic slide. The use of the Imagenet system enhanced the standardization 
and precision of the optic disc measurements and reduced interobserver 
variability and measurement bias.'" 22 The vertical cup-to-disc ratio (further 
referred to as cup-disc ratio) as measured by imagenet was used in our study. 
Subjects with a cup-disc ratio ~ 0.7 in at least one eye or asymmetry in cup-disc 
ratio ~ 0.3 between both eyes were considered as having an enlarged cup-disc 
ratio. 
All visual field charts were graded in a masked way by two independent 
graders, using all available data calculated by the statistical software of the 
perimeter to eliminate visual field defects caused by media opacities.']'" The 
graders were masked for all clinical characteristics including the cup-disc ratio, 
intraocular pressure, and familial relationship. Possible glaucomatous visual 
field defects were defined as field defects not explainable by other 
abnormalities, such as retinal (e.g. chorioretinal scars, macular degeneration, 
vascular obstructions), optic disc (e.g. optic disc drusen, optic disc pit, tilted 
disc), or neurologic (e.g. cerebrovascular accidents) disorders. Unreliable visual 
field tests were discarded in the analyses. 
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The diagnosis of primary open-angle glaucoma was based on the presence 
of a glaucomatous visual field defect in combination with a cup-disc ratio z 0.7 
in the affected eye 01' an asymmetry in cup-disc ratio z 0.3 between both eyes. 
Other Risk Factors 
Diabetes mellitus is a known risk factor for primary open-angle glaucoma.5• 26 
Also, a relation between elevated intraocular pressure and hypertension has 
been shown before." To investigate whether clustering of these concurrent 
disorders could account for familial aggregation of primary open-angle 
glaucoma, we evaluated presence of diabetes mellitus, and presence of 
hypertension as risk factors. Diabetes mellitus was defined as the use of anti-
diabetic medication, which was assessed using a questionnaire. Hypertension 
was defined as a systolic bloodpressure of 160 mmHg 01' over, 01' a diastolic 
bloodpressure of95 mmHg or over, or use of blood pressure lowering drugs. 
Statistical Analyses 
Prevalence of glaucoma was compared between siblings and offspring of 
glaucoma cases and siblings and offspring of controls. Prevalence figures were 
adjusted for age and gender. Multiple logistic regression analysis was used to 
estimate the risk of glaucoma for siblings and offspring, with the odds ratio 
serving as an approximation of relative risk. Odds ratios were adjusted for age 
and gender, and in addition analyses also for presence of diabetes mellitus and 
hypertension. Interaction between genetic factors and diabetes and hypertension 
was studied by performing stratified analyses, as well as performing analyses on 
the full data set including product terms for diabetes and proband status (case or 
control), and hypeltension and proband status. 
Survival analyses (Kaplan-Meier product-limit survival analysis) were 
performed to calculate cumulative risks of glaucoma, elevated intraocular 
pressure and enlarged cup-disc ratio. These cumulative risks are estimations of 
the absolute lifetime risk. Subjects above 80 years were pooled to maintain 
unbiased estimates. 28 The log-rank test was used to compare survival curves of 
64 
Genetic Risk oj Open-Angle Glaucoma 
relatives of glaucoma cases and of controls. All analyses were performed with 
the BMDP statistical package." 
The attributable risk of genetic factors to the occurrence of primary open-
angle glaucoma in the exposed and general population was estimated nsing the 
formulas developed by Miettinen.30 The attributable prop0l1ion for genetically 
exposed (Ape) was calculated with the formula 
RR-1 Ape=--
RR 
where RR is the relative risk. The attributable proportion for the total 
population (App) was calculated with 
App=Ape*Pe 
where Pe is the proportion genetically exposed in the cases. 
Table 1. Characteristics ojSiblillgs ojGlaucolI/a Cases alld o/Colltrols 
Siblings 
of Cases of Controls Difierence 95%CI 
(n=61) (n=142) 
Age in years 72.3 (l.l) 7504 (0.8) ·3.0 , ·5.7, ·0.3 
Women (%) 52.8 (6.3) 57.9 (4.2) ·5.1 ·19.9,9.7 
Hypertension (%) 38.0 (6.0) 34.3 (4.0) +3.7 ·10.5,17.9 
Diabetes mellitus (%) 11.9 (3.0) 3.8 (2.0) +8.1 , 0.9,15.3 
Mean intraocular pressure (mmI-Ig_ 14.7 (004) 13.1 (0.3) +1.6 • 0.6,2.5 
Intraocular pressure> 21 mmHg t (%) 4.1 (1.9) 0.7 (1.2) +304 ·1.0,7.8 
Intraocular pressure lowering therapy (%) 15.0 (2.9) 1.4 (2.0) 13.5 , 6.6,20.5 
Mean cup-disc ratio 0.54 (0.02) 0046 (0.01) +0.08 • 0.04,0.12 
Cup-disc ratio;;: 0.7 or asymmetry:? 0.3 (%) 32.8 (4.5) 6.5 (3.0) +26.3 , 15.8,36.8 
Visual field defcct l (%) 33.7 (4.8) 10.8 (3.4) +22.8 ' 11.3,34.4 
Prevalence of giallcoma§ (%) lOA (2.5) 0.7 (1.7) +9.7 • 3.8,15.6 
All figures are, if appropriate, adjusted for age and gender. Values in parentheses arc standard errors of the mean. 
* Statistically significant difference (p < 0.05) 
I Subjects with intraocular pressure lowering therapy were excluded. 
t All visual field defects caused by retinal abnormalities, optic disc abnormalities (except glaucoma), or neurologic 
disorders were excluded. 
§ Glaucoma was defined as the presence of a visual field defect, wilh no other causes, in combination with a cup-
disc ralio ~ 0.7 or asymmetry ~ 0.3. 
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RESULTS 
The mean age of the siblings of the glaucoma cases was 72.3 years (Table I). 
The siblings of the control subjects were on average 3.0 years older (95% CI 
0.3, 5.7; adjusted for gender). The mean age of the offspring of the glaucoma 
cases was 42.2 years, whereas the offspring of the control subjects were 3.5 
years older (95% CI 1.3, 5.7; Table 2). 
Table 2. Characteristics ofOfftprillg ofGlal/coma Cases allll ofColllrols 
Offspring 
afCases of Controls Difference 95%CI 
(N=86) (n=201) 
Age in years 42.2 (0.9) 48.7 (0.6) -3.5 • -5.7, -1.3 
Women(%) 43.8 (5.5) 45.7 (3.6) -1.9 -14.7,11.0 
Hypertension (%) 7.3 (2.9) 7.9 (1.9) -0.6 -7.4,6.2 
Diabetes mellitus (%) 1.2 (0.6) 0.0 (0.0) +1.2 -0.4, 2.7 
Mean intraocular pressure (mmHg) 14.7 (0.3) 13.6 (0.2) +1.2 • 0.5, 1.9 
Intraocular pressure> 21 mmHg t (%) 1.3 (1.0) 0.5 (0.6) -0.8 -1.5,3.1 
Intraocular pressure lowering therapy (%) 0.0 (0.0) 1.5 (0.7) 1.5 -4.2,1,2 
Mean cup-disc ratio 0.52 (0.01) 0.49 (0.01) +0.03 0.0,0.06 
Cup·disc ratio:? 0.7 or asymmetry :? 0.3 (%) 11.9 (3.4) 9.2 (2.2) +2.7 -5.3, 10.8 
Visual field defect: (%) 3.6 (1.3) 0.5 (0.9) +3.1 • om, 6.3 
Prevalence of glaucoma§ (%) 1.1 (0.7) 0.0 (0.0) +1.1 -0.4, 2.7 
All figures are, if appropriate, adjusted for age and gender. Values in parentheses are standard errOrs of the mean. 
t Statistically significant ditIerence (p < 0.05) 
I Subjects with intraocular pressure lowering therapy were excluded. 
1 All visual field defects caused by retinal abnormalities, optic disc abnormalities (except glaucoma), or neurologic 
disorders were excluded. 
§ Glaucoma was defined as the presence of a visual field delect, with no other causes, in combination with a cup-
disc ratio;;!; 0.7 or asymmetry;;!; 0.3. 
Siblings of glaucoma cases had a significantly higher intraocular pressure 
and cup-disc ratio than siblings of controls. Intraocular pressure lowering 
therapy occurred statistically significant more often in siblings of cases. In 
offspring, similar trends were found for mean intraocular pressure and cup-disc 
ratio, but differences were smaller and only statistically significant for 
intraocular pressure. There was no statistical significant difference in 
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intraocular pressure lowering therapy. The prevalence of glaucoma in the 
siblings of glaucoma cases was 10.4% (n=6) compared to 0.7% (n=l) in the 
siblings of controls (Table 3; prevalence odds ratio 14.7; 95% Cl 1.7, 130; 
adjusted for age and gender). In offspring of cases, glaucoma prevalence was 
1.1 % (n= 1), while this was not present among offspring of controls. The higher 
frequencies were independent of presence of diabetes mellitus or hypertension 
(Table 3). We found no statistical evidence for interaction between familial risk 
and diabetes mellitus or hypertension (data not shown). 
Table 3. Odds Ratios a/Glaucoma Features/or First Degree Relatives 
Intraocular pressure> 21 mmHgt Cup-disc ratio ~ 0.7 or asymmetry;:: 0,3 
+ OR' OR' + OR' 
Siblings 
of cases II 48 10.5 9.8 21 41 8.6 
of controls 3 121 (2.7,41.0) (2.5. 38.9) 7 135 (3.4,21.9) 
Offspring 
of cases I 81 ) 0.6 0.6 9 76 ) 1.3 of controls 4 187 (0.1,6.1) (0.1,5.5) 18 181 (0.5,3.1) 
Visual field dcfcct§ Diagnosis of glaucoma 1 
+ OR' OR' + 
Siblings 
of cases 19 40 4.8 5.1 6 55 
of controls 14 107 (2.1,1l.l) (2.2, 12.2) 123 
Offspring 
of cases 3 82 ) 7.5 7.5 I 84 of controls 4 188 (0.7,76.9) (0.7,76.5) 0 194 
The relative risks offamily members in the control group are sct to l.0. 
OR= Odds ratio, with 95% confidence interval between parenthesis. 
adjusted for age and gender 
t adjusted for age, gender, and presence of hypertension or diabetes mellitus 
t or intraocular pressure lowering treatment. 
OR' 
) 14.7 (1.7, 130) 
OR' 
9.2 
(3.5.24.1) 
1.3 
(0.5,3.1) 
OR' 
16.6 
(1.9, 147) 
i Visual field defects caused by retinal or optic disc abnonnalities (except glaucoma), or neurologic disorders were 
excluded. 
~ Glaucoma was defined as a visual field defect in combination with a cup-disc ratio?: 0.7 or asymmetry in cup-
disc ratio?: 0.3. 
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Figure 1. Lifetime risk of elevated intraocular pressure 
(lOP> 21 mmHg) 01' therapy /0 lower the lOP. 
Figures I and 2 show the 
lifetime risks of elevated 
intraocular pressure and 
enlarged cup-disc ratio in 
relatives of glaucoma cases 
and controls. Lifetime risk 
of elevated intraocular 
pressure was 42.5% in 
relatives of glaucoma cases 
compared to 6.7% in 
relatives of controls (risk 
ratio 6.3, 95% CI 2.1, 19.2; 
log-rank test p=0.0003). 
Lifetime risk of enlarged 
cup-disc ratio was 62.2% in 
relatives of glaucoma cases 
compared to 16.6% in 
relatives of controls (risk 
ratio 3.8, 95% CI 2.3, 6.1; 
log-rank test p<O.OOO I). 
Figure 3 shows the Kaplan-
Meier lifetime risks of 
glaucoma. The lifetime 
absolute risk of glaucoma at 
the age of 80 years was 
22.0% for relatives of cases 
compared to 2.4% for 
relatives of controls (risk 
ratio 9.2, 95% CI 1.2, 73.9; 
log-rank test p=0.0002). 
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Figure 2. Lifetime risk ofVCDR 2 0.7 01' asymmetlY 
in VCDR between both eyes 2 0.3 
The attributable 
proportion was calculated 
using the ratio of the 
lifetime cumulative risks of 
glaucoma in relatives as the 
best approximation of the 
true relative risk for genetic 
factors (RR=9.2) in the Ape 
and App formulas (see 
methods). The attributable 
proportion 
genetically 
was 89%, 
89% of 
among the 
exposed (Ape) 
indicating that 
the familial 
occurrence is genetically 
determined. The proportion 
exposed cases (Pe) was 
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Figure 3. Lifetime risk of glaucoma, defined as a 
visual field defect ill combination with a VCDR ;> 0.7 
or asymmetlJ' in VCDR between both eyes;> 0.3. 
calculated as the ratio of case probands with affected relatives (n=7) divided by 
the total number of case pro bands (n=38) with relatives who were at least 44 
years of age (minimum age of glaucoma in our study). The 
attributable proportion of genetic factors to the overall occurrence of glaucoma 
in the general population (App) was calculated to be 16.4%. 
DISCUSSION 
The main finding of this study is that the prevalence of glaucoma, enlarged cup-
disc ratio, and of elevated intraocular pressure is much higher in siblings and 
offspring of glaucoma cases than in relatives of non-affected subjects. The 
lifetime risk of glaucoma was 22% in relatives of glaucoma cases, almost 10 
times higher than in controls. Our findings suggest that at least one sixth of all 
glaucoma in the general population may be due to a genetic component. 
Enlarged cup-disc ratio was the earliest feature of glaucoma in relatives. 
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Former family studies were limited to clinic-based families or glaucomatous 
disorders, which are nowadays not regarded as adult-onset primary open-angle 
glaucoma. Often data from a large number of ophthalmologists were used, 
which may have introduced non-standardized diagnosis. Advantages of our 
study were that we ascertained glaucoma cases and controls from the same 
population-based cohort, minimizing selection bias. We did not rely on history 
data, but examined all first-degree relatives, and assessed each feature of 
glaucoma separately in a masked fashion to ensure an unbiased diagnosis. We 
aimed at full ascertainment, and approached all glaucoma cases of our source 
population. Asceltainment in our study was high, and was velY similar among 
both groups. Therefore, it is unlikely that selective participation explains our 
results. Unfortunately, the number of case probands was relatively low, which 
limited the statistical power of our study. Although confidence intervals were 
wide, the risk estimates reached statistical significance. 
Glaucoma is a disease which develops slowly and only becomes manifest at 
an older age. As a result, genetically exposed relatives may not have expressed 
the disease yet at the time of investigation. By censoring these individuals in the 
survival analyses, the true absolute lifetime risks for relatives are 
approximated." For simple genetic disorders, an absolute risk of 50% is 
compatible with autosomal dominant inheritance, and 25% with autosomal 
recessive inheritance". For complex disorders as glaucoma, the interpretation of 
these propOltions for mode of inheritance is not as straight forward. Different 
genes are likely to be involved, each with their own mode of inheritance and 
interaction with environmental factors. 
In general, magnitude of any exposure in the etiology of disease may be 
quantified by its relative and attributable risks. We found a relative risk of 9.2 
for genetic factors, which is higher than the effect of any other risk factor 
known. In contrast, the population attributable risk was approximately 16%, 
which was rather low. This suggests that other, non-genetic, factors determine 
the overall occurrence of glaucoma to a great extent. 
Unlike fonner family studies, we investigated each feature of glaucoma 
separately. We found that relatives of glaucoma cases had a higher frequency of 
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enlarged cup-disc ratio, but even in the "normal" cup-disc range their ratio was 
on average higher. From Figures I and 2 it can be concluded that enlarged cup-
disc ratio was the earliest manifestation of familial aggregation. As expected, 
elevated intraocular pressure or pressure lowering therapy occurred more often 
in relatives of glaucoma cases. Yet, the majority of relatives who had been 
newly diagnosed with glaucoma had normal intraocular pressures. The high 
prevalence of glaucoma therapy among relatives of cases may be a result of the 
selective treatment by ophthalmologists of patients with positive family history. 
In summary, we have demonstrated that relatives of glaucoma cases are at a 
10 times increased risk of developing glaucoma. Not intraocular pressure, but 
enlarged cup-disc ratio was the earliest expression of genetic exposure. Whether 
this is caused only by genetic factors, or also by gene-environmental 
interactions has to be fiuther investigated. Other, yet unknown, non-genetic 
factors seem to playa major role in the overall occurrence of glaucoma in the 
general population. 
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CHAPTERS 
CUP-To-DISC RATIO 
OPHTHALMOSCOPY 
VERSUS 
SEMI-AuTOMATED MEASUREMENT 
ABSTRACT 
Objective: To determine the correlations between ophthalmoscopic estimations 
and the measurements with a semi-automated il)1age-analysis device of the 
vertical cup-to-disk ratio (VCDR) in the human optic disk. 
Participants: All subjects aged 55 years or older from the population-based 
sample of 6777 ophthahnologically examined subjects from The Rotterdam 
Study of whom gradable optic disk transparencies of at least one eye and 
ophthalmoscopy data of the same eye were available. 
Methods: Indirect as well as direct ophthalmoscopy were performed in 
mydriasis to assess the VCDR. Optic disk transparencies made with a 
simultaneous stereoscopic telecentric fundus camera were analyzed with a 
semi-automated measurement system (Topcon Imagenet). 
Results: In 5143 subjects the mean ophthalmoscopic VCDR was 0.30 (SE 
0.0021; range 0.00, 1.00) compared to a semi-automatically measured VCDR of 
0.49 (SE 0.0019; range 0.04, 0.86; difference 0.19; p<O.OOOI). The overall 
correlation between both methods was moderate (correlation coefficient 0.61 
(SE 0.11 )), and lower in small optic disks. Semi-automated optic disk 
measurements correctly identified 76% of the glaucoma cases (as defined using 
visual field data and ophthalmoscopic data about the optic disk). 
Conclusion: Semi-automated measurements of the VCDR are larger than the 
ophthalmoscopic VCDR estimate with a moderate correlation. The inter-
observer variability using Imagenet was smaller, compared to the 
ophthalmoscopic assessments, and Imagenet was better standardized, which is 
important for epidemiological surveys and follow-up studies. 
Cup-to-disc ratio: Ophthalmoscopy versus Automated Measurement 
Reliable assessment of the vertical cup-to-disk ratio (VCDR) is essential for 
the diagnosis and monitoring of primary open-angle glaucoma (POAG). 
Unfortunately, ophthalmoscopic estimation of the VCDR has a low 
interobserver agreement (kappa 0.57', correlation coefficient 0.652). The more 
favorable interobserver agreement (coefficient of variability 3-28%3) ofrecentiy 
introduced semi-automated systems may be advantageous for glaucoma 
research. These systems were shown to detect morphometric optic disk changes 
as small as 50-100 fun.' Yet, the question may rise to what extent results of 
previous studies using ophthalmoscopy are interchangeable with more recent 
studies using semi-automated systems. In addition, it is uncertain whether semi-
automated measurements have better diagnostic accuracy than ophthalmoscopic 
estimates. 
Semi-automated measurement of the VCDR with Imagenet involves three-
dimensional topographic mapping of the optic disk surface, using digital images 
of the optic disk. The cup is outlined using strict criteria, based on topographic 
data, and not on pallor. There is no intrinsic measurement variability; however, 
operator input in outlining the disk may account for small measurement 
variability (1-12%).3 
Previous studies on the correlation between semi-automated measurement 
and ophthalmoscopy are lacking. A study on 35 eyes showed an only moderate 
correlation (weighted kappas 0.45-0.52) between clinicians estimating VCDR 
from stereo-photographs and semi-automated measurements.' Vertical cup-disk 
ratio estimations from photographs are known to be larger than 
ophthalmoscopic ones.' Using ophthalmoscopic VCDR estimations, the 
presence or absence of POAG could be correctiy identified in 90% of the 
subjects.' However, these figures are not yet known for semi-automated 
measurements. 
Though proven to be less reproducible, ophthalmoscopy still is the major 
screening tool for the detection ofPOAG. Therefore we aimed at answering the 
following questions: do ophthalmoscopy and semi-automated measurement give 
the same VCDR estimate? If not, what is the extent of the difference? What is 
the linearity of the relationship, given that there is a difference in means? In 
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addition, we determined the diagnostic accuracy of semi-automated 
measurements for the presence ofPOAG according to ophthalmoscopic criteria. 
METHODS 
The present study was performed as part of the baseline phase of The 
Rotterdam Study, a population based cohort study among residents, aged 55 
years and over.' The study has been approved by the Medical Ethics Committee 
of the Erasmus University and written informed consent was obtained from all 
participants. 
Of all 10,275 eligible persons, 69% (n=6777) underwent an 
ophthalmological examination performed by three medical doctors (MDs). The 
examination included measurement of best corrected visual acuity and corneal 
curvatures. Pupils were dilated with tropicamide 0.5% and phenylephrine 5%. 
Monocular indirect and direct ophthalmoscopy (Zeiss, Germany) were 
performed to assess VCDR. The optic cup was defined based on its contour and 
on the course of small blood vessels on the disk and not on pallor. The border of 
the optic disk was defined as the inner border of the peripapillary scleral ring. 
Next, optic disk transparencies were made with a simultaneous stereoscopic, 
telecentric fundus camera (Topcon TRC-SS2, Topcon Optical Company, 
Tokyo, Japan). Of all 6777 examined subjects in the Rotterdam Study, on 5143 
subjects both ophthalmoscopic and semi-automated VCDR measurements on at 
least one optic disk were available. 
Stereo transparencies fronl both eyes of all individuals were digitized and 
analyzed by two technicians with the Topcon Imagenet, using the module for 
the retinal nerve fiber layer height. The system's hardware, its software modules 
and reproducibility of measurements have previously been described.' The 
technician marked four points on the disk margin, defined as the inner border of 
the peripapillary scleral ring of Elschnig or the outer border of the neural rim if 
the scleral ring was not visible. Next, the program fitted the best ellipse around 
the four points to outline the disk margin. The technician subsequently marked 
five to eight corresponding points along retinal landmarks as blood vessels on 
both members of a stereo pair. These points were equally spaced outside the 
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disk's perimeter at 0.5 to 0.75 disk diameters from the disk margin. Imagenet 
used these points to define a retinal zero-reference plane and the parallax 
between corresponding points on the image pair to determine the topography of 
600 to 800 points within the optic disk relative to this zero-reference plane. To 
determine the margin of the cup, 36 vertical planes were established, 
perpendicular to the zero-reference plane and radially extending from the center 
of the disk to the disk margin at 10-degree intervals. At the intersection of the 
disk surface and each vertical plane, the most elevated point on the disk margin 
was determined. Relative to this point, more centrally located points that were ~ 
150 flln lower, were by convention 8 considered to be within the cup margin 
(Figure 1). The disk area, VCDR, and neural rim ratio (neural rim width divided 
by disk diameter at 36 equally spaced points along the disk circumference; 
Figure 1) were automatically calculated from the topographic data. If 
topographic information from an image point was ulll'eliable due to low image 
quality, topographic information was interpolated from surrounding reliable 
image points. Disks in which more than 10% of the image points were 
unreliable, were excluded from this study. Disk measurements were corrected 
for magnification by the eye and camera system to obtain measurements in 
absolute size units using a modified Littmann correction factor calculated from 
Neural 
rim '~_/ 
Disk 
spherical refractive equivalents and 
corneal curvatures: 
All subjects that had reliable semi-
automated measurements and 
ophthalmoscopy data of at least one 
optic disk were included in this study. 
The diagnosis POAG was made on 
the presence of a visual field defect 
(after other causes had been excluded), 
Figure 1. Schematical drawing oj optic . .. . 
disc characteristics as calculated by the 1lI comblllatlOn With an 
semi-automated measurement device. ophthalmoscopic VCDR ;, 0.5 or 
Vertical clip-to-disc ratio ~ CliP diameter / asymmetry in this VCDR between both 
Disc diameter. Nellral rim ratio ~ Rim 0 3 d 'd f 
width / Disc diameter. eyes;, ., an no eVI ellce 0 
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secondary glaucoma. Methods have been described in detail before. lO Briefly, 
visual fields were screened with a suprathl'eshold screening test (Humhrey 
Visual Field Analyzer, Zeiss, Germany). Confirmatory kinetic Goldmann 
perimetry was performed if defects persisted on a repeated suprathreshold test. 
Monocular indirect and direct ophthalmoscopy was performed to assess the 
VCDR. Intraocular pressure was not used as a criterion for POAG. 
Glaucomatous disks on semi-automated measurements were defined as 
disks with a VCDR ~ 0.7, or asymmetry in VCDR ;, 0.3 between both eyes, or a 
minimal neural rim width <; 0.15. These criteria were based on the mean shift in 
distribution of semi-automated measurements to larger VCDRs compared to 
ophthalmoscopic assessments, and on available data on stereoscopic grading of 
disk photographs. II. 12 
Data analysis. 
In our analyses we included one eye per person and selected the eye which 
had the stereo transparency with the highest photographic quality. A weighted 
kappa was calculated to compare ophthalmoscopic estimates with the 
categorized semi-automated imagenet measurements. Means for semi-
automated measurements and ophthalmoscopic VCDR estimations were 
compared with the paired Student's t-test and linear regression analysis. 
Pearson correlation coefficients were calculated for all subjects together. To 
study differences in ophthalmoscopy between observers we calculated the 
correlation coefficients for each of the three physicians. Fmthermore, we 
studied whether the disk area calculated with Imagenet had an influence on the 
estimation of the VCDR by stratifYing in tertiles of disk area. The percentage of 
interpolated points was taken as a measure of photographic quality, and was 
adjusted for in all analyses. 
In order to determine the diagnostic accuracy of Imagenet measurements, 
the sensitivity was calculated as the proportion of all subjects with POAG 
(using ophthalmoscopic disk assessment) who had a glaucomatous disk on 
semi-automated measurement. The specificity was defined as the proportion of 
correctly identified subjects without POAG. 
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To estimate within- and between-technician variation of semi-automated 
measurements, two technicians measured the same set of 25 at random selected 
transparencies at two, four, and nine months after the start of the 12-month 
measuring period. Weighted kappa values for within- and between teclmician 
variation were calculated. As the respondents were seen only once by one MD 
at a time, we could not calculate intra- and intel'Observer differences on 
ophthalmoscopy. 
Table 1. Influence of differellt physicians Oil the lillear association betIVeeu 
ophthalmoscopic estimates alld semi-flutomated lIIeaSlirelllellts ofVCDR. 
MDI 
"'ID 2 
MD3 
Correlation coefficient 
0.632 (0.106) 
0.629 (0.108) 
0.655 (0.106) 
Figures between parentheses are standard errors of the mean. 
RESULTS 
Figure 2 shows a scatter plot of ophthalmoscopic estimations and semi-
automated measurements. For the separate MDs the weighted kappas were 0.14, 
0.22, and 0.23, respectively. The weighted kappa for all MDs together was 0.18. 
The mean ophthalmoscopically estimated VCDR was 0.30 (SE 0.0021; 
range 0.00, 1.00) compared to a VCDR of 0.49 (SE 0.0019; range 0.04, 0.86) 
measured with the image-analyzer (difference 0.19; 95% CI 0.186 - 0.194; 
p<O.OOO I). The cumulative frequencies of ophthalmoscopic estimations and 
semi-automated measurements are shown in Figure 3; a clear shift to the right is 
visible for imagenet measurements compared to ophthalmoscopic estimates. 
The two methods showed a moderate correlation (coefficient 0.61 (SE 0.11; 
p<O.OOI). The correlation between ophthalmoscopic VCDR assessment and 
Imagenet assessment of VCDR varied little and not significantly between each 
of the three MDs (Table I). To determine whether a MD was influenced by disk 
dimensions, the correlation between both measurements by teltile of disk area 
(measured with Imagenet) is given in Table 2. The correlation between both 
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Figure 2. Comparison behveen ophthalmoscopic estimates of VCDR and semi-
automated measurements. Each mark represents the measurements of one eye. The 
solid line is the lineal' regression line. calculatedfor all the measurements (correiation 
0.64). Also regression lines for each of the three MDs are shown (dotted and dashed 
lines). 
methods was higher in large disks (disk area> 2.56 mm2) than in small disks 
(disk area < 2.17 mm2; test for trend: p = 0.02). Regression lines for the separate 
MDs and for all MDs together are shown in Figure 2. 
In this study, 37 persons had POAG according to Ollr ophthalmoscopic 
criteria (see methods). Of these, 28 subjects had on Imagenet a VCDR <: 0.7, or 
asymmetry <: 0.3 or a minimal neural rim width" 0.15, yielding a sensitivity of 
75.7% (28/37) for detecting POAG. The specificity of the semi-automated 
measurements was 72.7% (3712/5106). We did not perform these calculations 
for ophthalmoscopic VCDR estimations, because we used these as a reference 
for the POAG diagnosis in our study. 
The optic disk transparencies were digitized and analyzed by two 
technicians. The weighted kappa for inter-technician variability was 0.85. The 
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weighted kappa for intra-technician variability was 0.92 for technician I and 
0.88 for technician 2. 
Because of logistic reasons it was only possible for one MD to evaluate each 
subject. This made it impossible to evaluate the inter- and intra-observer 
reliability of the VCDR estimates of the different MOs. 
Table 2. Illfluellce of disk area as measured witlt Imagellet 011 tlte linear associatioll 
bellVeell oplttltalmoscopic estimates alld Imagellelmeasuremellts ofVCDR. 
Disk area Correlation coefficient Difference between 
(tertiles) ophthalmoscopy and 
Imagenet measurements 
<2.17mm2 0.523 (SE 0.145) 0.21 (SE 0.004) 
2.17 M 2.56 l1un2 0.562 (SE 0.142) 0.19 (SE 0.004) 
> 2,56 1111112 0.617 (SE 0.152) 0.17 (SEO.004) 
Test for trend: p~0.02 p <0.0001 
The correlation coefficient shows the strength of linear association between the ophthalmoscopic VCDR and its 
Imagenet counterpart. The strength of this association increased with disk size (statistically significant, p=O.02), 
while the difference between the ophthalmoscopic VCDR and Irnagenet decreased with increasing disk size 
(statistically significant, p< 0.0001). 
DISCUSSION 
We found that Imagenet measurements of VCDR were moderately 
correlated (1'=0.63) with ophthalmoscopic estimates. Differences between 
methods were more pronounced both in disks with ophthalmoscopic small and 
large VCDRs. FUlihermore, differences were largest in larger disks. 
The low weighted kappa is in contrast with the finding of a study (kappa 
ranging from 0.45 to 0.52 for different observers 5) in which Imagenet 
measurements were compared with visual gradings of optic disk transparencies. 
This partly can be explained by the difference in method used to estimate the 
VCDR (because ophthalmoscopy is often less accurate than grading of fundus 
abnormalities). FUtihermore, we saw a shift to the right in the distribution of 
semi-automated VCDR measurements compared to the ophthalmoscopic 
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VCDRs. This 'systematic' difference can result in a marked decrease of a 
kappa. In addition, as is usual in daily practice, we used different MDs for 
ophthalmoscopy, 
100,-------------------------~==~~~-----------
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Figure 3. Cumulative prevalences oj ophthalmoscopic estimates oj the VCDR (solid 
line) and oj Imagenet measurements (dashed line) in aile eye oj 5134 subjects. 
Differences between semi-automated VCDR measurements and 
ophthalmoscopic estimates of the VCDR can be explained by several factors. In 
our study, monocular ophthalmoscopy was performed, while Imagenet 
measurements are based on stereoscopic transparencies. Monocular assessment 
differs from the stereoscopic counterpart, because frequently the point at which 
the cup starts has to be inferred and cannot be perceived. It has been found that 
stereoscopic estimations yield larger estimates,6 This may partly explain why 
the mean of semi-automated VCDR measurements was higher than its 
ophthalmoscopic counterpart. Furthermore, it can not be excluded that the 
observer has been biased by the area of pallor and peripapillary atrophy on 
ophthalmoscopy. Contrastingly, semi-automated measurement disregards color 
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differences of the optic disk, and has strict criteria for defining the cup. 
Ultimately, the issue which of both methods most accurately reflects reality 
might only be resolved using histopathological data. 
Unfortunately, no other studies were found that compared ophthalmoscopy 
with other disk measuring methods. Studies that cOl'l'elated manual stereoscopic 
disk planimetlY with semi-automated measurements also found moderate 
correlations of 0.6i3 and of 0.77. 14Since planimetry, grading of stereoscopic 
transparencies of the optic disk, and semi-automated VCDR measurement all 
correlate moderately with ophthalmoscopic VCDR estimations, all are equally 
eligible to be an alternative to ophthalmoscopic estimations. Additional 
characteristics, such as measurement variability, interobserver agreement, and 
costs determine therefore their usefulness. In the ophthalmoscopic lower VCDR 
range, semi-automated measurements were lower than the ophthalmoscopic 
estimates, while this was reversed in the upper VCDR range (Figure 2). 
Furthermore, we found a lower correlation between both methods in small optic 
disks. A possible explanation may be that semi-automated systems cannot 
distinguish between the entrance of the blood vessels in the disk and the neural 
tissue lining the cup. Therefore, the central depression caused by the entering 
blood vessels is regarded as the cup, and thus may be overestimated. Since 
small optic disks are known to have on average also smaller cups, this 
overestimation will pal1icularly affect semi-automated measurements in small 
disks, and not in larger disks. The lower correlation in smaller disks is in 
keeping with our findings that the automated measurements were higher in 
disks with ophthalmoscopic low VCDRs. 
One advantage of our study is that we avoided selection on optic disk 
characteristics, and therefore our results can be generalized to daily practice. 
Former studies on applicability of semi-automated measurement systems chose 
cases and controls 15. 16 based on contrasting health status of the optic disk. This 
may have overestimated diagnostic accuracy and correlation between both 
methods. The present study is the first that rep0l1s sensitivity and specificity of 
Imagenet measurements of VCDR for the diagnosis POAG in a general 
population. 
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At present there is no gold standard for assessment of the VCDR. Most 
methods differ in the way they define or detect the cup and optic disk border. 
No method has the ideal sensitivity and specificity for detecting POAG. To 
define POAG in this study only ophthalmoscopic VCDR data were used, no 
semi-automated measurements. First reason for this was that ophthalmoscopic 
VCDR estimates are the usual estimates used in clinical practice at this moment 
and in the past, and we wanted to compare the newer semi-automated 
measurements with the 'old' method as reference. Secondly, we wanted to 
examine to which amount the semi-automated measurements were able to 
separate POAG cases from non-POAG cases. By choosing the ophthalmoscopic 
estimates for use in POAG diagnosis the possibility exists that some POAG 
cases were missed because of inaccurate ophthalmoscopic VCDR estimates. 
This can also have its effect on the sensitivity and specificity values of the new 
method which is being tested. Futthermore, clinical measurements, often 
performed by several examiners, can introduce extra variation in these 
measurements and result in noise, decreasing the strength of the association 
between the two measurement methods. 
The sensitivity and specificity figures were not velY high, suggesting that 
Imagenet measurements of the VCDR are not as good as ophthalmoscopic 
evaluation of the optic disk in identifying POAG. A possible explanation could 
be that with ophthalmoscopy the observer, when estimating the VCDR, also 
takes other characteristics of the optic disk into account, such as eccentric 
location of the cup, irregular cupping and notching. In this way a better 
discrimination between glaucomatous and not-glaucomatous optic disks may be 
achieved. 
The interteclmician agreement. of Imagenet measurements in our study was 
higher than previously reported values of interobserver agreement on 
ophthalmoscopy. This is of benefit in epidemiological follow-up studies with 
different observers, apart from the advantage that pictures can be kept while 
ophthalmoscopy never can be checked again after some time. In addition, semi-
automated devices have been proven to detect longitudinal optic disk changes 
more sensitively than clinical assessment of stereoscopic photographs. 11 
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However, cooperation of the subjects, and media opacities can be a more 
distorting factor for the semi-automated measurement than for ophthalmoscopic 
assessment by an experienced observer. In the absence of available comparison 
data on the performance of ophthalmoscopic and semi-automated 
measurements in follow-up studies, there is no scientifically based preference 
possible. To date, it seems that ophthalmoscopic assessment has a higher 
diagnostic value in cross-sectional research, while semi-automated 
measurements may prove to be superior in longitudinal studies. 
In conclusion, we found that Imagenet measurement of the VCDR shows 
moderate correlation with ophthalmoscopic VCDR assessment. The methods 
use different criteria for defining the cup and maybe also the disk. Most 
impOliantiy, inter-observer variability of semi-automated measurements is 
smaller, and the measurements are better standardized compared to the 
ophthalmoscopic assessments, which is essential in follow-up studies. 
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CENTRAL CORNEAL THICKNESS 
DISTRIBUTION AND ASSOCIATION WITH 
INTRAOCULAR PRESSURE 
ABSTRACT 
Purpose: To perform a cross-sectional study on the distribution of central 
corneal thickness in an elderly population, and its association with intraocular 
pressure (lOP). 
Methods: In 395 subjects (352 control subjects, 13 subjects with ocular 
hypertension and 30 cases with primary open-angle glaucoma (pOAG)) of 55 
years and over from the population-based Rotterdam Study, central corneal 
thickness was measured with ultrasonic pachymetry (Allergan Humphrey 850) 
and the lOP with the Goldmann applanation tonometer. 
Results: Mean central corneal thickness in the 352 control subjects was 537.4 
flm (95% Confidence Interval (Cl) 533.8, 540.9; range 427-620 flm). It was 
similar between right and left eyes, with a maximal difference of 42 flm. There 
were no gender differences and there was no significant association with age. 
Linear regression analysis of central corneal thickness against lOP showed an 
increase of O. I 9 mmHg in lOP with each 10 flm increase in central corneal 
thickness (95% CI 0.09, 0.28). This association was similar in both eyes and in 
both sexes. The 13 subjects with ocular hypettension had a 16.0 flm (95% CI -
2.6, +34.6) thicker cornea than controls (p=0.093), whereas the 30 cases with 
POAG had a 21.5 flm (95% CI 8.8, 34.1) thinner cornea compared to controls 
(P=O.OOI). 
Conclusion: Mean central corneal thickness was similar to that found in 
clinical studies and was slightly higher in subjects with ocular hypettension and 
significantly lower in POAG cases. The lOP was positively related with central 
corneal thickness. Central corneal thickness may influence the division between 
normal and elevated lOP when using a simple cut-off point of21 mmHg. 
Cenfral Corneal Thiclrness 
The intraocular pressure (roP) is used for diagnosis and management of 
many eye diseases, including several types of glaucoma. Goldmann applanation 
tonometry is the gold standard, but provides only an estimate of the real lOP. 
The accuracy of this estimate is dependent on many factors.' To a large extent 
errors can be avoided by a correct measurement technique? However, errors 
caused by other factors, notably central corneal thickness which influences the 
rigidity of the cornea, cannot be avoided. On the other hand on statistical 
grounds a cut-off value of 21 mmHg is widely used to differentiate between 
normal and abnormal lOP. When calibrating his tonometer, Goldmann assumed 
central corneal thickness to be 0.5 mm and he stressed that variation in 
thickness could theoretically affect the measurement.' Information on 
differences in corneal thickness from in vivo measurements has subsequently 
become available.4•7 
Central corneal thickness can be measured with an optical method and with 
ultrasound, the latter being more reliable.8 Ultrasonic pachymetry has been 
proven to be very accurate and reproducible with a lower inter- and 
intraobserver variability than optical pachymetty.8.10 Most studies on central 
corneal thickness have been performed in clinic-based populations. We set out 
to study in a cross-sectional way the distribution of central corneal thickness in 
an elderly population-based COh0l1 and the association between central corneal 
thickness and lOP. 
SUBJECTS AND METHODS 
This study was performed as part of the Rotterdam Study, a population 
based cohort study of 7983 residents, aged 55 years and over, of a suburb of 
Rotterdam, The Netherlands. The Rotterdam Study aims at investigating 
determinants of chronic disabling ophthalmologic, cardiovascular, 
neurogeriatric, and locomotor diseases." The study has been approved by the 
Medical Ethics Committee of the Erasmus University and a written informed 
consent was obtained from all pat1icipants. The baseline measurements were 
performed between 1990 and 1993. This baseline phase consisted of an 
extensive home interview, registration of used medication and a medical 
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examination, including a complete ophthalmological examination, as described 
in detail before. I' Overall response was 77.7%. 
The first follow-up part of the Rotterdam Study, including a medical and 
ophthalmological examination, was performed in 1993 and 1994. During two 
months in this follow-up study, central corneal thickness was measured with 
ultrasound pachymetry (Allergan Humphrey 850) in all subsequent, at random 
(using postal codes) invited, pat1icipants (n=408) visiting the examination 
center for routine follow-up. Only persons with normal corneae on slit-lamp 
examination and no eye surgery within the last year were included in this study 
(n=365, 89.5%). Of these 365 pal1icipants, 352 subjects had no ocular 
abnormalities (we call them here control subjects); 13 subjects were diagnosed 
as ocular hypertension cases, of whom eight were treated to lower the lOP. In 
addition to the at random pal1icipating subjects, as many cases with POAG from 
the first phase of the Rotterdam Study as possible were reinvited to take part in 
the present study. In total 30 cases with POAG participated, all under treatment 
for their glaucoma at the moment of this study. In a pilot study we found no 
influence on lOP of the ultrasound measurements. Thus prior to the lOP 
measurements five consecutive measurements of the central corneal thickness 
were taken on both eyes, and the mean of the middle three (in terms of 
numerical value) measurement values was used in the analyses. For the POAG 
cases the examiner was masked with regard to the category in which the 
pat1icipants belonged. 
Ocular hypel1ension was defined as an lOP greater than 21 mmHg, or use of 
lOP lowering medication, with a cup/disc ratio of less than 0.5 and no 
glaucomatous visual field defect in the baseline phase of the Rotterdam Study. 
The diagnosis POAG was based on the presence of a glaucomatous visual 
field defect on kinetic Goldmann perimetry in the same baseline phase, 
combined with either a vertical cup/disc ratio of 0.5 or greater, or a difference in 
cup/disc ratio of 0.2 or more between both eyes, or an lOP greater than 21 
mmHg, or use of lOP lowering medication, with open and normal anterior 
chambe)' angles, without any other abnormality that could explain the visual 
field defectY 
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Only one eye per person was used in the analyses. In subjects without 
POAG and in bilaterally affected subjects with POAG, a random choice was 
made between the right and left eye. In monocular POAG, the affected eye was 
used in the analysis. Mean central corneal thickness was calculated for the 
entire group and also for right and left eyes separately in men and women. 
Student's t-test and linear regression was used for comparing means between 
groups. The effect of central corneal thickness on lOP was evaluated with linear 
regression analysis. All analyses were performed with the BMDP statistical 
package." 
Ta ble 1. Characteristics of the stlldy poplIlatiolt 
Control Subjects with 
subjects ocular hypertension 
N 352 
Age (years) 72.0 [l.21] 
Age range (years) 55.1 ·90.2 
Women(%) 43.4 
Body mass index (kglm2) 25.7 [0.60J 
Systolic blood pressure (llunHg) 137.2 [4.IOJ 
Diastolic blood pressure (nunHg) 72.2 [2.12] 
Left eyes (%) 63.8 
AU figures (when appropriate) are adjusted for age andlor gender. 
Numbers between square brackets are standard errors ofthe meall . 
. Sec methods for description of groups. 
RESULTS 
13 
65.1 [2.34] 
64.7-72.1 
37.5 
27.1 [1.I3J 
158.9 [7.64J 
79.9 [3.96J 
36.9 
POAG 
cases 
30 
64.7 [0.35J 
69.7 - 88.5 
51.1 
26.1 [0.17J 
139.2 [1.I6J 
73.8 [0.60J 
51.1 
In Table I, the general characteristics of the 395 subjects are given. The 
controls had a significantly higher age than the other groups. Other 
characteristics were comparable. The mean central corneal thickness in the 
control subjects was 537.4 j.lm (95% CI 533.9, 540.9; it ranged from 427 till 
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620 J.lm). In Figure I the distribution of the central corneal thickness in the 365 
random selected subjects (controls and ocular hypettension cases) is shown. 
30 r----------------------------------, There was no significant 
difference in corneal 
thickness between right and 
left eyes (mean difference 
4.22 J.lm; 95% CI -2.68, 11.3; 
P=0.23; maximum difference 
42 J.lm) nor between men and 
24 
18 
12 
6 
o 
IA.- ~ !§ .Eb women (difference 4.39 J.lm; 
li-"-,,,--=--, 95% CI -2.52, 11.3; P=0.21). 
400-419 420·439 440-459 HO· 4H 480-4~9 ~OO·519 521)-SH S40·559 5~-519 sao· Sgg 600-619 HO·639 
Contral cornoal thlcknoss (~m) Central corneal thickness did 
EZ2l Mon ~ Woman 
F· 1 D' ·b··r I I I' /a . not change significantly with IgUl'e • Isl1'1 utlOn OJ centra cornea IlIG leSS 1I1 
the 365 random selected subjects (controls alld age (0.061 J.lm/year; 95% CI -
oClilar hypertension cases). 0.46, 0.58; P=0.82), similarly 
for right and left eyes, and for men and women. All corneal thickness 
measurements were performed during daytime (8.30 - 16.00 hour), and there 
was no association between central comeal thickness and time of examination. 
The mean central comeal thickness in the subgroups, and the differences in 
comeal thickness with the controls, are given in Table 2. In the ocular 
hypertension group we saw a slightly, although not significantly, higher central 
comeal thickness than in the controls (+16.0 J.lm, 95% CI -2.6, +34.6; P=0.093). 
In the POAG group the mean central comeal thickness was significantly lower 
than in the controls (-21.5 J.lm, 95% CI -34.1, -8.8; P=O.OOI). Past surgical or 
different medical treatments in the POAG group had no effect on the central 
corneal thickness. 
The association between lOP and central corneal thickness was examined 
only in the subjects without lOP lowering treatment. The lOP rose with 
increasing central corneal thickness (0.19 mmHg/lO J.lm; 95% CI 0.09, 0.28; 
P=O.OOO I; Figure 2). This regression coefficient did not change after adjustment 
for age and gender. Conversely, the corneal thickness increased with 2.23 
ftmll.O mmHg increase in lOP (95% CI 1.13,3.34; P=O.OOOI). 
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Table 2. Central corneal thickness and intraocular pressure of one eye per subject in the different subgroups 
N MeanCCT' SEt 95% CII Difference with controls Mean IOp§ SEt 95% CII Difference with controls 
(~m) (~m) p value (mmHg) (mmHg) p value 
Control subjects 352 537.4 1.80 533.8. 540.9 14.6 0.16 14.3, 15.0 
Ocular hypertension cases 13 553.4 8.50 534.8,571.9 +16.0 0.093 18.7 1.26 16.0,21.4 +4.05 0.000 
* Without IOP* lowering treatment 5 562.3 9.08 537.1,587.5 +25.0 0.100 23.6 0.51 22.2,25.0 +8.96 0.000 
* With IOp§ lowering treatment 8 547.8 12.6 517.8,577.7 +10.4 0.390 15.6 0.91 13.5.17.8 +0.98 0.347 
POAG 30 515.9 6.70 502.2, 529.6 ·21.5 0.001 14.3 0.75 12.8, 15.8 ·0.35 0.549 
All subjects 395 536.3 1.73 532.9,539.7 14.8 0.16 14.4,15.1 
All subjects with POAG were monitored and under treatment at the time of this study_ 
·CCT = Central corneal thickness 
rSE = Standard error of the mean 
:95% eI = 95 percent confidence interval 
§IOP = Intraocular pressure. 
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Figure 2. Association between central comealthickness and intraocular pressure. in 352 
control subjects and 5 subjects with ocular hypertension. all without JOP-lowering 
treatment. The black solid line represents the lineal' regression line. the dashed lines 
represent the borders of the 95% confidence interval. • ~ subject with ocular 
hyper/ensioll. 
DISCUSSION 
The main findings in our population-based study are that the mean central 
corneal thickness in normal eyes with 537.4 !Jm is similar as in clinic-based 
studies and that it is positively associated with lOP. In clinical studies the mean 
central corneal thickness varied from about 520 !Jm, using optical pachymetry 
4.6,7,18 to 540 !Jm with ultrasound.9,19 Subjects with ocular hypeliension had in 
this study a slightly higher corneal thickness than controls; on the other hand, 
POAG cases had a significantly lower central corneal thickness than the 
controls. Age had only a small and non-significant inverse relation to corneal 
thickness, in agreement with other studies 6,7,19 and similarly there were no sex 
differences.6,7 
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Central corneal thickness was similar in right and left eyes. Previous studies 
with optical pachymetry 6.20 did show a systematic right-left difference. This 
may be due to a measurement error in the optical method when the 
measurement is not perpendicular to the cornea. Such a measurement error does 
not occur with the ultrasound pachymeter used here, as this gives only a reading 
when the probe is perpendicular to the cornea. Indeed, other studies using 
ultrasound pachymetry could also not find a right-left difference.9,10 
In the ocular hypertension group central corneal thickness was slightly 
higher than in controls, which has also been found by others. I '.17 In the POAG 
group, however, the central corneal thickness was significantly lower than in the 
controls, in contrast to the findings in other studies, possibly because of a too 
low power or the use of the less accurate optical pachymetry in those 
studies.7.14.16,17 
As expected from the literature 6.21 we found that central corneal thickness 
and lOP were positively related. On the other hand a negative relation between 
central corneal thickness and lOP was found in a study on 45 subjects with 
unilateral retinal detachment.' However, eyes with a retinal detaclnnent often 
show flare in the anterior chamber and vitreous pointing to a breakdown of the 
blood retina barrier and to release of inflammatOlY mediators. These may have 
influenced the corneal thickness in that study', as also was confirmed in another 
one.22 
It is still not clear whether the relation between lOP and corneal thickness is 
artifactual rather than real. It may be caused by a measurement error in 
applanation tonometry due to differences in corneal thickness, as already 
suggested by Goldmann himself.' Another possible explanation is a 
physiological effect of lOP on the cornea, resulting, for example, in an increase 
of collagen fibers or rigidity in the cornea or a combination of both. Based on 
our data, we cannot prove or reject any of the possibilities. To examine this, 
invasive measurement of the lOP is necessary.21 
The diagnosis ocular hypettension, and high-tension and low-tension POAG 
is usually made on an arbitraty lOP cut-off point of 21 mmHg, based on 
statistical grounds and convention rather than on causative factors. Our findings 
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on central corneal thickness, showing a definite relation with IOP values, may 
have an impact on values around the "magic" 21 mmHg. Many patients with an 
elevated lOP, but without other glaucomatous features, might merely have a 
thicker cornea but not a higher risk for glaucoma. 
In conclusion, the mean central corneal thickness in normal eyes of this 
elderly population was 537.4 fun and it showed a maximal difference between 
eyes of 193 fun. Within a person the maximum difference between the right and 
left eye was 42 fun. Mean central corneal thickness was slightly higher in 
subjects with ocular hypertension and significantly lower in POAG cases. The 
lOP as measured by applanation tonometry is positively related to central 
corneal thickness. From these experiments it cannot be concluded if this is only 
due to measurement errors or also to a direct effect of the lOP on the corneal 
thickness. Due to the variation in central corneal thickness in the population the 
measured lOP can be an underestimation or an overestimation of the real 
hydrostatic lOP, and thus can be a confounder in the subdivision between 
normal and elevated lOP, and therefore also between normal-pressure and 
hypertensive POAG, when using an absolute cut-off point of2l mmHg. 
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CHAPTER 7 
RISK OF ACUTE ANGLE-CLOSURE GLAUCOMA 
AFTER DIAGNOSTIC MYDRIASIS 
ABSTRACT 
Purpose. To report the incidence of acute angle-closure glaucoma (AACG) 
after diagnostic mydriasis in non-selected subjects aged 55 years and over. 
Methods. Of all subjects in the population-based Rotterdam Study (n=7,983), 
6,760 participated in the ophthalmological examination and received 
tropicamide 0.5% and phenylephrine 5% eyedrops for diagnostic mydriasis. No 
selection was made such as on intraocular pressure, presence of narrow anterior 
chamber angles or history of glaucoma. After the ophthalmological examination 
all participants received thymoxamine 0.5% drops in both eyes and were 
warned for the symptoms of AACG. 
Results. In two subjects an attack of AACG developed in one eye. Both cases 
were initially treated with thymoxamine 0.5% eyedrops and oral acetazolamide 
0.500. Subsequently peripheral iridotomies were performed with a Nd-Y AG-
laser, and both eyes healed without other sequelae. 
Conclusion. In non-selected (Caucasian) subjects of 55 years of age or older the 
incidence of AACG after this type of diagnostic mydriasis is 0.03%. 
Risk of Acute Allgle-Closure Glaucoma 
Diagnostic mydriatics are very widely used in ophthalmological clinical 
practice. In most cases they are essential for an adequate examination of the 
ocular media and fundus, especially by non-ophthalmologists. I However, the 
use of mydriatic agents can provoke an attack of acute angle-closure glaucoma 
(AACG), with rise of the intra-ocular pressure (lOP) up to 80 mmHg within a 
few hours, and with a risk of permanent damage to the optic nerve?' 3 Only early 
recognition of the, in most cases substantially, elevated lOP and subsequent 
reduction of the pressure, can save the visual capacity of the eye involved. 
The risk of inducing an AACG attack might be a reason why many general 
practitioners, internists and other non-ophthalmologic physicians are reluctant 
to dilate pupils for ocular examination. Also when an (ophthalmic) 
epidemiological study is started, the question will rise, whether it is safe to use 
mydriatics in all participants. Patticipants in an ophthalmic epidemiological 
study may be selected based on an inclusion criterion that requires an inspection 
of the anterior chamber angle (e.g. using the van Herick method 6). On the other 
hand this may create bias. From the literature no data could be obtained on the 
risk of AACG when, with or without prior examination, all subjects in a 
population-based study received mydriatic drops. Thus, in The Rotterdam Study 
all participants were scheduled to receive mydriatic eyedrops for fundus 
examination and photography. The purpose of this paper is to report the 
incidence of AACG after diagnostic mydriasis in non-selected subjects in a 
population aged 55 years and over. 
METHODS 
The Rotterdam Study is a large population-based follow-up study in which 
7,983 subjects participated. Of these 97% were of Caucasian origin. This study 
aims at investigating chronic disabling ophthalmologic, cardiovascular, 
neurogeriatric, and locomotor diseases in subjects aged 55 years and over.4 The 
ophthalmological patt focussed on primaty open-angle glaucoma and age-
related macular degeneration. The study has been approved by the Medical 
Ethics Committee of the Erasmus University and a written informed consent 
was obtained from all participants. The baseline phase (1990-1993) consisted of 
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an extensive home interview, followed by a medical and complete 
ophthalmological examination in the research center.' The ophthalmological 
examination included an estimation of the width of the anterior chamber angle, 
by comparing the thickness of the cornea with the distance between cornea and 
iris (method of van Herick 6) The anterior chamber angles were roughly divided 
in normal open angles (grade 4 or 3) or narrow angles (grade 2 or I). In order 
not to create unacceptable bias all palticipants received tropicamide 0.5% and 
phenylephrine 5% mydriatic eye drops, regardless of the presence of a shallow 
anterior chamber angle or a history of angle-closure or primary open angle 
glaucoma. After the examination, all received as a miotic one drop of 
thymoxamine 0.5% in each eye. Every participant was warned to notity the 
investigator immediately, when blurred vision, pain or redness around the eye 
was noted. In those cases, the intraocular pressure was re-measured (in 
mydriasis) at the end of the ophthalmological examination. In case these 
symptoms started later on at home the pmticipants were told to warn the 
investigator or their general practitioner. 
Table 1. Participallts alld refusal of mydriatics ill the ophthalmological part of the 
Rotterdam Study. 
Age~category Men % refusal of Women % refusal of Total % refusal of 
(years) mydriatics mydriatics mydriatics 
55·64 1,098 l.l (n~12) 1,463 0.5 (n~8) 2,561 0.8 (IF20) 
65·74 1,051 1.3 (n~14) 1,349 1.0 (n~13) 2,400 1.1 (n~27) 
75·84 503 1.2 (n~6) 887 1.6 (IFI4) 1,390 1.4 (IF20) 
85+ 89 3.4 (n~3) 320 3.4 (n~ll) 409 3.4 (n~14) 
Total 2,741 1.3 (n~35) 4,019 l.l (n~46) 6,760 1.2 (n~81) 
Prevalence figures were calculated in the whole group of participants 
(prevalence of AACG) and in subgroups of gender and age (prevalence figures 
of narrow chamber angle). Linear regression analysis was used for calculating 
the effect of age and refraction on the prevalence of narrow chamber angles. 
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Logistic regression analysis was used to estimate the risk of having narrow 
chamber angles in women versus men, with the odds ratio serving as an 
approximation of relative risk. All analyses were adjusted for age and gender 
when appropriate. All analyses were performed with the BMDP statistical 
package. 13 
RESULTS 
Of the 7,983 participants in the baseline phase, 6,760 (84.7%) subjects 
underwent an ophthalmological examination, and 6,679 (98.8%) of these 
received mydriatic drops for ophthalmoscopy and fundus photographs (Table 
I). A small patt (1.2%) of the patticipants refused the mydriatics. This refusal 
was only significantly dependent on age and not on gender or presence of 
narrow chamber angles or to eye-complaints in the past (Table 2). Subjects with 
a history of ophthalmological examinations did not refuse more frequently. 
Table 2. Relative risks/or refl/salojmydriafics. 
Odds Ratio· 95% Confidence interval 
Aget 65-74 2.14 1.04,4.44 
75-84 3.27 1.56,6.91 
85+ 8.02 3.53, 18.2 
Gcnder f 0.82 0.49, 1.35 
Narrowangie§ 1.22 0.29,5.lt 
Visit to ophthalmologist~ 0.96 0.59, 1.58 
Odds ratio from mUltiple logistic regression \\ith age, gender, presence oCnan-ow chamber angle, and eye-complaints in past in the model. 
Reference: age-category 55·6.-1 years 
Gender: females wrsus males 
§ Presence versus absence of narrow chamber angle (method ohan Herick) 
1 Visits versus no .. isits to ophthalmologist for examination (other than for prescription of glasses) in the past. 
The overall-prevalence of narrow anterior chamber angles was 2.2 %. The 
prevalence rates in the different age and gender categories are given in Table 3. 
With increasing age the chance on having a narrow angle increased with 3.0 
percent/year (Odds ratio 1.03; 95% CI 1.01, 1.04; p=0.0043); after adjustment 
for refraction this effect of age disappeared (Odds ratio 1.0 I; 95% CI 0.99, 1.03; 
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p=0.32). Women had a two times higher chance of having a narrow anterior 
chamber angle than men (Odds ratio 2.0, 95% CI 1.4,3.0; adjusted for age and 
refraction). 
Table 3. Prevalellce of lIarrolV allterior chamber allgles. 
Age-category Men Women Total 
(years) % % % 
55-64 1.2 (0.33) 2.4 (0.40) 1.9 (0.27) 
65-74 1.4 (0.37) 2.4 (0.42) 2.0 (0.29) 
75-84 1.4 (0.52) 2.8 (0.55) 2.3 (0.40) 
85+ U (Ul) 5.7 (1.31) 4.7 (1.05) 
Total 1.3 (0.22) 2.8 (0.26) 2.2 (0.18) 
Figures between parentheses arc standard errors of the mean. 
Of the 6,679 subjects who received mydriatic eye-drops, two participants 
(0.03%; 95% CI 0.01-0.04; Table 4) developed an AACG attack after 
mydriasis. They both were initially treated medically (thymoxamine 0.5% and 
acetazolamide 0.500), and subsequently were referred to the Department of 
Ophthalmology of the University Hospital Rotterdam. In both cases peripheral 
iridotomies were performed with a Nd-Y AG-laser, and both cases had no 
sequelae of the AACG attack. 
DISCUSSION 
The results of this study show that only about 1 in 3000 unselected persons 
aged 55 years and over will develop AACG after the use of tropicamide 0.5% 
and phenylephrine 5% eye drops. The number of cases which developed AACG 
in our study is too low to perform (reliable) statistical analyses on risk factors 
forAACG. 
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Table 4, Characteristics of respondellts with acute allgle-closure glaucoma after 
instillillg diagnostic mydriatics 
Case 1: 
Case 2: 
Female, 64 years of age 
Visual acuity 
Refraction· 
Slitiamp examination 
Applanation tonometry 
Pressure rise till 
Male, 63 years of age 
Visual acuity 
Refraction' 
Slitlamp examination 
Applanation tonometry 
Pressure rise tiII 
right eye 
1.00 
+4.87 
left eye 
1.00 
+5.13 
both eyes narrow chamber angle (van Herick 
grade 1-2), no cataract 
25 IllmHg 24 mlllHg 
69mmHg 351llmHg 
after I hour. Nomtalized after 2 hours with 
medical treatment, after which in both eyes 
peripheral iridotomies were performed with a 
Nd-Y AG-Iaser. 
1.00 
+3.87 
1.00 
+3.75 
both eyes normal chamber angle (van Herick 
grade 3-4), cortical cataract 
19mmHg 
unknown 
21 mmHg 
66mmHg 
after 2-3 hours. With medical treatment 
pressure was lowered to 16 mmHg OD and 18 
mmHg OS. In both eyes peripheral iridotomies 
were performed with a Nd~YAG~laser . 
• Spherical equivalent (spherical value plus half cylinder value) 
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Narrow anterior chamber angles were present in 2.2% of the subjects, when 
estimated with the method of van Herick. In the literature no data could be 
found on the distribution of narrow chamber angles in the general population. 
The higher risk of women of having a narrow chamber angle was in agreement 
of a study using gonioscopy. 8 The effect of age on the presence of narrow 
anterior chamber angles as described in the literature 8 was in agreement with 
our findings. However, after adjustment for refraction this effect disappeared. A 
possible explanation for this is the swelling of the lens with increasing age. 
Both tropicamide and phenylephrine are seen as relatively safe mydriatics. 9. 
10 Phenylephrine affects lOP and the anterior chamber depth only little and is 
rapidly reversed in action by thymoxamine.9• 10 Also tropicamide does not cause 
a significant rise in lOP and the effects of tropicamide can be quickly 
counteracted by acetazolamide. 1O 
Recently the absence of AACG after mydriatic drops in a population based 
survey on 4,870 subjects has been reported.9 However, all subjects were 
previously selected on the absence of a shallow anterior chamber. Exclusion of 
subjects from a study, based on the size of the anterior chamber angle of the 
eye, determined by gonioscopy or with van Herick's method 6, can introduce 
unwanted bias. It is known that eyes with open anterior chamber angles on 
gonioscopy still can develop an AACG after mydriasis." Even an elevation of 
the lOP after mydriasis is compatible with normal open anterior-chamber angle 
and also a gonioscopically closed anterior angle chamber is compatible with no 
rise in lOP after mydriasis. 10 Therefore, gonioscopy seems of limited value to 
predict which eyes will develop angle-closure glaucoma in response to pupillary 
dilatation. 
In mydriasis the sensitivity of funduscopy in the detection of diabetic 
retinopathy is considerably improved.' The same holds for macular and 
peripheral retinal disorders. The advantage of a more sensitive fundus 
examination in mydriasis outbalances in our view the risk of luxating AACG. 
Moreover, in 8% of the cases at risk " AACG would have occurred within 2 
years, usually late in the evening without prior knowledge and without medical 
supervision. This may lead to a higher chance of permanent loss of visual 
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capacity in the affected eye. Therefore, we consider mydriasis with the 
mentioned mydriatics to be a relatively safe procedure, provided that evelybody 
has been thoroughly informed about related complaints and that a physician is 
available for re-examination of the subjects. Good contact with eye care 
facilities in the neighbourhood is necessalY in order to reduce the risk of 
permanent damage to the eye. 
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GENERAL DISCUSSION 

General Discllssion 
In this thesis several cross-sectional studies are described, which were based on 
a general population of about 7000 subjects aged 55 and older, on a subset of 
this population, or on their relatives. The aim of the open-angle glaucoma 
(OAG) research in the Rotterdam Study is to increase our knowledge of its 
etiology and risk factors. Despite the many studies performed in the past, still 
very little is known about these two. 
This thesis focuses on the prevalences of OAG or its determinants in a 
general population. I define in this thesis open-angle glaucoma as all forms of 
idiopathic glaucoma from which especially congenital, (acute) angle-closure, 
pupillary-block, and secondary glaucomas found on examination or by history 
taking, have been excluded. Among others, these secondary glaucomas include 
traumatic glaucomas, post-inflammatory and neovascular glaucoma. The 
idiopathic form of glaucoma is often called primary open-angle glaucoma 
(POAG) or simple chronic glaucoma. Because we felt that during baseline 
pseudoexfoliation glaucoma - a secondary form of glaucoma with open anterior 
chamber angles - has not sufficiently been excluded, we write in some articles 
about OAG instead of POAG. The familial or hereditary aspects of OAG were 
studied by examining first-degree relatives of OAG cases from the Rotterdam 
Study and comparing them with first-degree relatives of age and gender 
matched controls from the same study population. Relative and absolute life-
time risks were calculated to quantifY the risks. 
This is the first large population-based study that used semi-automated 
measurements of the optic nerve head to diagnose glaucoma. Semi-automated 
measurements give more objective results of optic disc characteristics. These 
semi-automated measurements were compared with the funduscopic estimates. 
Prevalence of OAG 
Several large population-based studies on POAG have been performed in recent 
years in different parts of the world. Most showed prevalence figures of about 
1 % (Framingham Study I 1.2%, The Baltimore Eye Survey 2 1.1 %, Barbados 
Eye Study J 0.8% in white subjects). These findings are comparable with the 
0.9% found in the Rotterdam Study. Only the Beaver Dam Eye Study and the 
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Blue Mountains Eye Study found a higher overall prevalence (2.1% 4 and 
3.0% 5 respectively). However, despite the similar prevalence figures reported 
by the different studies, almost all studies used different criteria for diagnosing 
OAG and different algorithms for examination and classification of the subjects. 
This raises the question, whether all those study results are actually comparable. 
It could well be that, when the criteria and algorithms of one study (e.g. the 
Baltimore Eye Survey) were applied on another population (e.g. in the 
Netherlands or in Australia), very different prevalence figures would be found, 
giving evidence for regional differences in the prevalence of OAG. In order to 
test this, I applied the criteria of other population-based studies on our study-
population. This showed 12-fold differences in prevalence, when comparing the 
resulting prevalence figures. The real differences will probably be smaller, 
because only the criteria were used and not also the examination algorithms, 
which would be unfeasible. It might mean that regional differences in OAG 
prevalence do exist. To study these, and to really compare studies, criteria for 
diagnosing OAG and examination algorithms should be standardized, to reduce 
the amount of noise when pooling data of studies on glaucoma. We recently 
resumed tt'ying to formulate criteria for OAG in epidemiologic studies 
(International Working Group on Defining Glaucoma in Eye Examination 
Surveys - personal communication). Standardizing diagnostic methods and 
definitions could be of much benefit for future epidemiologic glaucoma 
research and might result in actual progress in the understanding of the 
glaucoma etiology. As time of the respondents and of the examiners often is the 
limiting factor in these studies, I would propose in future studies as minimum 
examination algorithm: 
• Optic disc characteristics measurements (e.g. vertical cup/disc ratio, 
neuroretinal rim, disc and rim area) should be either captured on (stereo) 
transparencies or recorded digitally, so that they may be examined at a later 
time with (semi) automated image analysis systems. These systems have to 
be compared to each other, and need to have a good correlation for the used 
parameters. Automated analysis improves objectivity of the measurements, 
especially in follow-up studies. One system for automated optic disc 
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analysis would be preferable, but due to technological innovations new 
systems and techniqnes will be developed in the future. Therefore, criteria 
for optic disc characteristics should be reviewed regularly and when needed 
adapted . 
• Visual field testing has to be performed in all subjects who are physically 
and mentally able to perform a reliable visual field test, and not in a 
(selected) subset. The gold standard for visual field testing at this moment is 
the Humphrey full-threshold static perimetry of the central 24 or 30 degrees 
of the visual field. However, one single field test that shows a defect, 
although reliable performed, is not enough to conclude that there really is a 
visual field defect. The Humphrey test is known about its learning effects. 6 
This means that in case of abnormalities or unreliable tests at least two 
visual field tests should be performed, before one can conclude that there is 
a visual field defect. A disadvantage of this system is the relatively large 
amount of time needed to perform the tests, also resulting in fatigue 
especially in older subjects, often resulting in less reliable and false-positive 
tests. 7 New full-threshold testing algorithms (SITA, frequency doubling 
perimetry) are being developed and tested at this moment, all trying to 
reduce testing time and improving accuracy of the test. 8·11 It is too early to 
select one for the epidemiologic screening algorithm. Perhaps a 
suprathreshold screening test is at this moment the most realistic, feasible, 
and accepted visual field screening test in a (large) population-based 
epidemiologic study, eventually followed by a repetition of the same test 
when the first test was abnormal or unreliable to eliminate or minimize 
learning effects. All abnormal screening tests should be confirmed with full 
threshold perimetty for definite diagnosis of visual field defects. Kinetic 
Goldmann perimetty in the hands of an experienced perimetrist is a good, 
although less sensitive ", alternative for subjects in which automated testing 
cannot be performed reliably, especially in the elderly . 
• Ophthalmoscopy has to be performed in mydriasis in all subjects, regardless 
of the presence or history of glaucoma or status of anterior chamber angle. 
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This is necessaty to detect other causes of visual field defects or other forms 
of glaucoma than POAG . 
• The anterior chamber angle has to be assessed with gonioscopy in all 
subjects with visual field defects and in subjects with evident glaucomatous 
damage to the optic nerve head. 
As definition of definite OAG, I would propose the presence a visual field 
defect not due to retinal or neuro-ophthalmic causes, in combination with a 
VCDR L 0.7, or a minimal neuroretinal rim width of less than 0.10, or an 
asymmetry in VCDR L 0.3 between both eyes, with open anterior chamber 
angles. Optic disc characteristics should ideally be assessed using (semi) 
automated measurements. When a visual field can not reliably be performed, a 
VCDR :: 0.9 could be regarded as enough evidence for presence of definite 
glaucoma. These cut-off points for optic disc characteristics are based on 
statistical 97.5th percentiles of their distribution. 
Probable OAG could be defined as the presence of a visual field defect not 
due to retinal or neuro-ophthalmic causes, but without optic disc abnormalities 
suspect for OAG. Because of the large variation in optic disc characteristics, 
one could argue whether optic disc abnormalities suspect for OAG, but without 
visual field defect also should be classified as probable OAG. 
Visual field defects 
Techniques to examine the visual field of a patient undetwent a rapid change 
over the last decade with the introduction of computerized automated perimetty. 
Although the teclmique has improved, not much is known about the prevalence 
of visual field abnormalities in the general population. Only few studies on the 
prevalence of field defects and their causes were performed in the past. In the 
Rotterdam Study perimetry was performed in all participants to screen for 
OAG. We demonstrated a sharp rise in prevalence of field defects from 3% in 
the 55-64 year old subjects to 19% above 85 years of age. The large amount of 
available data on the health status of all participants in the Rotterdam Study also 
made it possible to study the causes of field defects. FUl1hermore, because of 
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the large size of our study we had the opportunity to also detect more rare 
causes of visual field defects. Unfortunately no other studies are available for 
comparison of our data. Glaucoma and age-related macular degeneration were 
the main causes of visual field loss in the studied age categories. The 
importance of an intact visual field is shown by the association of visual field 
defects with the increased risk of falling and hip fractures. Not only visual 
acuity, but also visual field loss was related with a higher risk. In OAG the 
visual field can be considerably damaged before a patient notices any 
complaints. The early detection and treatment of OAG therefore also is 
important for elderly subjects to maintain their independence in the society. 
FamiliaVgenetic risk 
Since many years a genetic influence on OAG has been known, given various 
published pedigrees 13-23, and only recently specific genes/gene locations were 
identified. 24-29 However, actual risk estimates never were calculated to quantifY 
that risk in a general population. Studies in selected families showed impressive 
pedigrees, with different types of inheritance of glaucoma (or related disorders). 
Most studies suggested that genetic factors played an important role in the 
etiology of OAG, at least in the ~xamined subgroup. However, very few studies 
used (matched) control groups for comparison. Also, often only family history 
data were used, and not actual examination data, giving rise to recall bias. 
We designed a study using both OAG cases and controls from the same 
population to study the familial risks. Subjects from both groups were 
ascertained using the same examination methods, minimizing selection bias. 
We actually examined all first-degree relatives of OAG cases and controls, and 
studied all determinants of OAG separately. In order to deal with the age-
dependent expression of the disease we used a special statistical analysis 
technique, survival analysis, to compare both groups of relatives. 30,31 
This study showed that the prevalence of the separate glaucoma features 
(lOP, vertical cup/disc ratio (VCDR) and visual field defects) were all more 
prevalent in the relatives of OAG cases. The lifetime risk of OAG for relatives 
of OAG cases was 22%, almost IO times higher than in relatives of controls. 
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The enlargement of the cup-disc ratio was the first sign of increased familial 
risk. In contrast, the population attributable risk, which is the propOliion of 
OAG cases in the general population attributable to genetic factors, was 
approximately 16%, which was rather low. This suggests that other, non-
genetic, factors determine to a great extent the overall occurrence of OAG. 
Which factors are of impOliance has to be further studied. Further research into 
the genetic background of OAG can lead to new clues in its etiology, and 
maybe more important, in new and maybe better treatment possibilities. 
Optic nerve head measnrements 
For a long time, drawings of the optic nerve head were the only way of 
documenting optic disc characteristics. These ophthalmoscopic estimations are 
characterized by their large inter- and intra-observer variations. 32. 33 Even 
photography of the optic disc, and subsequent estimation or grading of the 
VCDR has been shown to be subject to considerable inter-observer variation. 32. 
33 Many older population-based studies 34·37 on OAG depended on 
ophthalmoscopic evaluation of the optic discs, often estimated by several 
different examiners, or grading of photographs. 2·5 Recently, new teclmiques and 
methods became available for objective measurement of optic disc 
characteristics. Computerized analysis of conventional stereoscopic optic disc 
photographs has been shown to be accurate and reproducible. 32.38.39 Also newer 
techniques, as laser scanning tomography of the optic disc, have shown 
promising results. These newer techniques can provide new insights in the 
pathogenesis of OAG when they are more accurate and reproducible than the 
ophthalmoscopic estimates. Their advantage, especially for follow-up studies, in 
which examiners often change, or differences in optic disc characteristics are 
small, will be clear. 
In the Rotterdam Study we performed ophthalmoscopy to estimate the 
VCDR in all participants. Also simultaneous stereoscopic photographs of the 
optic discs were made, which were later on analyzed with a semi-automated 
image analyzer (imagenet, Topcon, Japan). We compared the ophthalmoscopic 
estimations with their semi-automated counterpalis, and found an only 
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moderate correlation between both estimates. Different reasons for this are 
possible. In our study, monocular ophthalmoscopy was performed, while 
Imagenet measurements are based on stereoscopic transparencies, which often 
yield larger estimates. 22 Also, because the examiner was aware of other subject 
characteristics (as visual field status, lOP), a measurement bias can not be 
excluded. FUlihermore, the observer could be biased by the area of pallor and 
peripapillary atrophy on ophthalmoscopy; this is disregarded by the semi-
automated measurements, which only take three-dimensional topographic data 
into account to calculate the VCDR and other optic disc characteristics. 
Our study differs from other large population-based studies, because we 
used semi-automated optic disk measurements to assess evidence of optic nerve 
damage (enlargement of VCDR, narrow neuroretinal rim, asymmetry in 
cupping between both eyes). These measurements were unbiased by knowledge 
of visual field status or lOP of the subjects. FUlihermore, the semi-automated 
system used strict criteria for defining the cup margins, based only on 
topographic data, therefore reducing variation due to different observers, and is 
particularly interesting for follow-up studies. 40 Differences in techniques and 
criteria for defining the cup margins play an impol'tant role in the varying 
results of different studies. Even interpretation of photographs is subject to 
interobserver variation. 41 
In our population-based study we found the 97.5th percentiles of semi-
automated measurements of the VCDR were 0.70, similar to ophthalmoscopy. 
This means that both for measurement methods a cut-off point of 0.7 can be 
used, although for the ophthalmoscopic estimates interobserver variation can 
playa disturbing role. 
Central corneal thickness 
Intraocular pressure has for long been an important criterium for the diagnosis 
OAG. As already pointed out by Goldmann himself, the thickness and rigidity 
of the central cornea influence the accuracy of the lOP estimate, when 
measuring the lOP with an applanation tonometer. 42.43 With this equipment the 
force necessaty to flatten the cornea over a given area is measured in dynes 
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(marked on tonometer scale), which multiplied by ten equals the intraocular 
pressure in mmHg. 44 The corneal thickness is related to the rigidity of the 
cornea, and partly determines the amount of force necessary to flatten this area 
of the cornea. In the past several studies were performed, which showed 
different distributions of central corneal thickness (CCT) in various populations. 
However, mostly optical measurements were used, which are not always very 
accurate. The newel' ultrasound teclmique gives more accurate measurements of 
the CCT. Using this technique in a general population, we confirmed that the 
mean CCT was about 540 ~m, and that there were no significant differences 
between right and left eyes 45. 46, nor between both sexes. 47. 48 There was no 
relation between CCT and age. We found a slightly higher CCT in ocular 
hypertension cases, and a significantly lower CCT in OAG cases. A higher CCT 
in cases with ocular hypertension, subjects with an lOP> 21 mmHg without 
visual field loss or abnormal optic discs, has been found in more studies. 49·52 
One might hypothesize that cases with ocular hypertension, who do not develop 
OAG over many years, have no elevated lOP, but just abnormal corneal 
thickness or rigidity leading to false lOP readings. Also the positive relation 
between lOP and CCT was confirmed by our study. A study in a Mongolian 
population showed a strikingly similar effect of CCT on lOP. 53 However, due 
to study design and feasibility, we were not able to study or prove any causal 
relationships between CCT and lOP. It is plausible, that both a large and small 
CCT cause a measurement error in applanation tonometry. On the other hand, 
we can not reject that there is a physiological effect of lOP on the cornea. To 
study such a causal relation, invasive measurement of the lOP is necessary. 54 
For glaucoma diagnosis, this study shows again that the simple cut-off point of 
21 mmHg for lOP is not always applicable to everyone. 
Acute angle-closure glaucoma 
Studies on the incidence of acute angle-closure glaucoma in the past were 
hampered by a selection of subjects with open anterior chamber angles. 55 This 
selection often was performed to prevent the risk of inducing angle-closure 
glaucoma in participants with narrow angles, due to diagnostic mydriasis. Also, 
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m clinical practice often no mydriatics are given to subjects with narrow 
anterior chamber angles, because of the fear for resulting high lOP and damage 
of the visual function of the eye. However, even on gonioscopy open anterior 
chamber angles (,non-occludable' angles) are capable of causing a rise in lOP 
in mydriasis. 56.57 On the other hand, some subjects with gonioscopically closed 
anterior angle chambers show no rise in lOP in mydriasis. 56 Furthermore, 
subjects who respond to diagnostic mydriasis with a rise of lOP will probably 
also get high lOP's when they are at home in the evening or at night 
(physiologic mydriasis). They might not notice the elevation of lOP until pain 
arises or wait too long before going to a doctor with their complaints. In the 
Rotterdam Study, we gave all participants mydriatic eyedrops, regardless of 
their anterior chamber angle depth or history of glaucoma to prevent selection 
bias. As a precaution, we wal'lled all participants for possible complaints 
associated with acute angle closure. In only two of 6679 participants receiving 
mydriatics acute angle closure glaucoma developed. Both were sent to the 
outpatient department of the University Hospital Rotterdam, and were treated 
with Nd-Y AG laser iridotomies. Both recovered without visual acuity or visual 
field loss. In our experience, both tropic amide 0.5% and phenylephrine 5.0% 
are relatively safe mydriatics; the mydriasis and the pressure rise can 
respectively be counteracted by thymoxamine and acetazolamide. 55. 56 In our 
view, the benefits of a more sensitive fundus examination through dilated pupils 
outbalance the small increase in risk of inducing angle closure glaucoma after 
diagnostic mydriasis and the selection bias. It provides a way for an accurate 
retinal examination, and can serve as a selection method for subjects at risk for 
angle closure glaucoma, which with proper facilities can be treated before 
permanent damage to the eye occurs. 
With our studies we showed that there is an urgent need for standardized 
criteria for OAG in epidemiologic research. Discussion on these criteria was 
started a few years ago by us, and hopefully future studies will be more 
structured according to 'new' criteria and algorithms that have to be developed. 
Only in this way a reliable pooling of different population-based studies is 
possible, and more insight in the etiology and risk factors for OAG can be 
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gained. In the familial aggregation study we quantified the risk for first-degree 
relatives ofOAG cases, and concluded that there is a 'familial' factor. However, 
whether this factor is a genetic one, or an environmental or a combination of 
both has to be further studied. The semi-automated measurements of the optic 
disc are an important tool to get more objective and standardized measurements 
of optic disc characteristics related to OAG, and also improve comparison and 
pooling of data of different studies. When future (population-based) studies are 
using the same algorithms and criteria for OAG, smaller risk factors can be 
identified, and OAG cases of different studies can be pooled for more extensive 
research to genetic factors in the OAG etiology. Future research on OAG will 
probably mostly be on a genetic base, in order to find more clues in its etiology 
and pathogenesis, thereby also giving more statting-points for better therapeutic 
possibilities (e.g. nelll'oprotection). 
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The eye disease "glaucoma" has been known for a long time and the history of 
its concept is shotl1y described in chapter I. In time the definitions and our 
understanding of the disease underwent a major change. Intraocular pressure, 
visual fields and optic disc characteristics were recognized as important 
determinants in the course of the disease. Although new methods for examining 
the eye became available, still vety little is known about its etiology. 
The early detection of glaucoma is an important public health concern. 
Glaucomatous blindness may be prevented if the disease is diagnosed in time 
and treated adequately. However, once vision has been lost, it call11ot be 
restored at present time by any form of treatment. Because most patients with 
early glaucoma are asymptomatic, much (peripheral) visual field can be lost 
before the patient notices visual impairment. This means that routine screening 
of asymptomatic people is necessary to detect early glaucoma cases. 
There are many types of glaucoma. Primary open angle glaucoma (pOAG) 
is the most prevalent type of glaucoma in Western countries. This thesis focuses 
on (primaty) open-angle glaucoma (OAG). We could not sufficiently exclude 
pseudoexfoliation as a cause of glaucoma and that is why we use OAG instead 
of POAG in some chapters. All studies were performed based on data from 
examinations of subjects from the Rotterdam Study, a population-based cohort 
study of subjects aged 55 years and over. 
An important problem in quite a few studies on OAG in the past was the 
difference in criteria and methods used to diagnose and classifY OAG. These 
differences can result in different findings and make comparisons between 
studies difficult. Today glaucoma may be defined as a disease causing an optic 
neuropathy characterized by cupping of the optic disc with an associated visual 
field defect. In chapter 2 we present the prevalence figures of OAG in the 
Rotterdam Study. These figures are based on ophthalmic examinations in 6781 
subjects aged 55 years or over (6293 independently living subjects and 488 
living in nursing homes). The criteria for diagnosis of OAG were based on 
semi-automated measurements of the optic disc, such as vetlical cup-to-disc 
ratio (VCDR), minimal width of neural rim, or asymmetry in VCDR between 
both eyes, and visual field testing with kinetic Goldmann perimetty. Intraocular 
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pressure (lOP) was measured with Goldmann applanation tonometry. All 
separate criteria for the diagnosis of OAG wel'e assessed independently of each 
other. Also different criteria for OAG as used in other large population-based 
studies were applied on the data of the Rotterdam Study. Although the 
prevalence figures as reported by most population-based studies are more or 
less comparable, their criteria for OAG when applied on our population resulted 
in a 12-fold difference in prevalence figures (ranging from 0.1% to 1.2%). That 
is why we presented as proposal for uniform OAG criteria: a VCDR 2 0.7, 
asymmetry in VCDR between both eyes 2 0.3 or a minimal rim width < 0.1 0 
using (semi-)automated measurements, in combination with a visual field defect 
not due to retinal or neuro-ophthalmic causes. With these criteria we found an 
overall prevalence of OAG in the independently living subjects of 0.9% (95% 
CI 0.6, 1.1; 56 cases). Prevalence of OAG was two times higher in men than in 
women (Odds ratio 2.3, 95%CI 1.2, 4.5). The risk of OAG increased with 8% 
pel' year of age (95% CI 4.0%, 13.0%). Standardization of criteria and 
diagnostic algorithms will improve the comparability of different studies, to 
study regional differences, and also gives the opportunity of pooling data fi'om 
different studies to study (smaller) risk factors. 
In chapter 3 we describe our estimates of the prevalence and causes of 
visual field loss (VFL) and the association with impairment in daily life. 
Prevalences and causes were measured cross-sectionally in the Rotterdam Study 
cohort. Indicators of impairment were measured both cross-sectionally and 
prospectively. Visual fields were tested with a Humphrey suprathreshold test of 
the central 48 degrees. When a defect was present the test was repeated. 
Goldmann kinetic perimetry was performed when a defect was present after 
retesting. Data from the ophthalmological examinations, from the neurological 
examinations as well as histOlY data from ophthalmologists and general 
practitioners was used to determine the cause of visual field defect. Interview 
data on disability in daily life, reading, use of walking aids, falling and fractures 
was used to assess impairment. The overall prevalence of visual field defects 
was 5.5%, ranging from 1.9% in the youngest age-category to 17.0% in the 
oldest age-group. Glaucoma was the leading cause of a visual field defect at all 
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ages. Optic disc disease (other than glaucoma) and stroke were the second and 
third most common causes. After 75 years of age, age-related macular 
degeneration and retinal vascular occlusions were the second and third ranking 
causes. VFL was, independent from impaired visual acuity, associated with 
disability and a higher risk of falling and fractures. In 28% of all subjects with 
VFL, the subjects were unaware of the defect and had never visited an 
ophthalmologist except for glasses. 
About the genetic background of OAG still little is known, although genetic 
factors were already assumed to be of imp0l1ance since 1869 by von Graefe. 
Many pedigrees were published since that time and studies in selected 
populations showed different hereditary patterns. Often in these studies only 
family history data was used and family members were not actually examined. 
In chapter 4 we describe a study in which we evaluated whether glaucoma 
aggregates in families drawn from of a general population. We thereto selected 
all pro bands with OAG and a random selection of controls fi'om the population-
based Rotterdam Study. From these subjects all first-degree relatives were 
examined using a standardized protocol. Among relatives of cases, OAG 
prevalence was 10.4% among siblings and l.l % among offspring, while this 
was 0.7% and 0% among relatives of controls. Lifetime risk of elevated IOP 
was 42.5% in relatives of cases versus 6.7% in relatives of controls; of enlarged 
cup-disc ratio 62.2% versus 16.6%; and of OAG 22.0% versus 2.3%, yielding a 
risk ratio of 9.2 (95% CI 1.2, 73.9). The population attributable risk of OAG 
was 16.4%. We concluded that in a general population, relatives of OAG cases 
have a strongly increased risk of OAG. Surprisingly not intraocular pressure but 
enlarged cup-disc ratio was the earliest and most prominent feature of familial 
aggregation. FUl1her studies are needed to disentangle the genetic components 
of the increased familial risk. 
Reliable assessment of the vertical cup-to-disk ratio (VCDR) is essential for 
the diagnosis and monitoring of OAG. Unfortunately, ophthalmoscopic 
estimation of the VCDR has a low interobserver agreement. The recently 
introduced semi-automated image analyzers have been shown to be more 
reproducible and able to detect velY small changes over time. At this time, 
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though proven to be less reproducible, ophthalmoscopy still is the major 
screening tool for the detection of OAG. In chapter 5 we compared the 
ophthalmoscopic VCDR estimates with their semi-automated counterparts. In 
5143 subjects the mean ophthalmoscopic VCDR was 0.30 (SE 0.0021; range 
0.00, 1.00) compared to a semi-automatically measured VCDR of 0.49 (SE 
0.0019; range 0.04, 0.86; difference 0.19; p<O.OOOI). The overall correlation 
between both methods was moderate (correlation coefficient 0.61 (SE 0.11)), 
and lower in small optic disks. Semi-automated optic disk measurements 
correctly identified 76% of the OAG cases (as defined using visual field data 
and ophthalmoscopic data about the optic disk). Semi-automated measurements 
of the VCDR are larger than the ophthalmoscopic VCDR estimate with a 
moderate correlation. The inter-observer variability using semi-automated 
measurements was smaller, compared to the ophthalmoscopic assessments, and 
semi-automated measurements are better standardized, which is important for 
epidemiological surveys and follow-up studies. The 97.5 th percentiles of the 
VCDR distributions in our study-population was 0.70, both for semi-automated 
measurements and for ophthalmoscopic VCDR estimates. 
Also lOP is used for diagnosis and management of OAG. Goldmann 
applanation tonometry is the gold standard, but provides only an estimate of the 
real lOP. The accuracy of this estimate is dependent on many factors. To a large 
extent errors can be avoided by a correct measurement technique. However, 
errors caused by other factors, notably central corneal thickness which 
influences the rigidity of the cornea, cannot be avoided. Central corneal 
thickness can be measured with an optical method and with ultrasound, the 
latter being more reliable. Ultrasonic pachymetry has been proven to be very 
accurate and reproducible with a lower inter- and intraobserver variability than 
optical pachymetty. In chapter 6 we present data on the central corneal 
thickness in a randomly selected subset of subjects from the Rotterdam Study. 
In 395 subjects (352 control subjects, 13 subjects with ocular hypertension and 
30 cases with POAG) of 55 years and over, central corneal thickness was 
measured with ultrasonic pachymetty (Allergan Humphrey 850) and the lOP 
with the Goldmann applanation tonometer. Mean central corneal thickness in 
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the 352 control subjects was 537.4 Jlm (95% Confidence Interval (CI) 533.8, 
540.9; range 427-620 Jlm). It was similar between right and left eyes, with a 
maximal difference of 42 Jlm. There were no gender differences and there was 
no significant association with age. Linear regression analysis of central corneal 
thickness against lOP showed an increase of 0.19 mmHg in lOP with each 10 
fun increase in central corneal thickness (95% CI 0.09, 0.28). This association 
was similar in both eyes and in both sexes. The 13 subjects with ocular 
hypertension had a 16.0 Jlm (95% CI -2.6, +34.6) thicker cornea than controls 
(P=0.093), whereas the 30 cases with POAG had a 21.5 Jlm (95% CI 8.8, 34.1) 
thinner cornea compared to controls (P=O.OOI). In conclusion, the lOP as 
measured by applanation tOllometry is positively related to central corneal 
thickness. From these experiments it cannot be concluded if this is only due to 
measurement errors or also to a direct effect of the lOP on the corneal 
thickness. Due to the variation in central corneal thickness in the population the 
measured lOP can be an underestimation or an overestimation of the real 
hydrostatic lOP. Thus central corneal thickness can be a confounder in the 
subdivision between normal and elevated lOP, and therefore also between 
normal-pressure and hype11ensive POAG, when using an absolute cut-off point 
of21 mmHg. 
Diagnostic mydriatics are very widely used in ophthalmic clinical practice. 
In most cases they are essential for an adequate examination of the ocular media 
and fundus, especially by non-ophthalmologists. However, the use of mydriatic 
agents can provoke an attack of acute angle-closure glaucoma (AACG), with 
rise of the lOP up to 80 mmHg within a few hours, and with a risk of permanent 
damage to the optic nerve. This risk of inducing an AACG attack might be a 
reason why many general practitioners, internists and other non-ophthalmologic 
physicians are reluctant to dilate pupils for ocular examination. Also, in an 
ophthalmic epidemiological study pa11icipants may be selected based on an 
inclusion criterion that requires an inspection of the anterior chamber angle, 
which may create bias. In chapter 7 we describe the risk of inducing AACG in a 
screening protocol for OAG. In total 6,760 subjects participated in the 
ophthalmic examination and 6,679 (98.8%) of them received tropicamide 0.5% 
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and phenylephrine 5% eyedrops for diagnostic mydriasis. No selection was 
made such as on intraocular pressure, presence of narrow anterior chamber 
angles or history of glaucoma. After the ophthalmic examination all participants 
received thymoxamine 0.5% drops in both eyes and were warned for the 
symptoms of AACG. In two subjects an attack of AACG developed in one eye. 
Both cases were initially treated with thymoxamine 0.5% eyedrops and oral 
acetazolamide 0.500. Subsequently peripheral iridotomies were performed with 
a Nd-YAG-Iaser, and both eyes healed without other sequelae. This study 
shows that in non-selected (Caucasian) subjects of 55 years of age 01' older the 
risk of AACG after this type of diagnostic mydriasis is as low as 0.03%. 
Therefore, we consider mydriasis with the mentioned mydriatics to be a 
relatively safe procedure, provided that everybody has been thoroughly 
informed about related complaints and that medical care is available for re-
examination of the subjects in case of complaints. 
In chapter 8 all results are placed in a larger perspective. A proposal for 
standardizing OAG diagnosis and classification in epidemiologic studies is 
given. Standardized examination algorithms and definitions make pooling of 
data from different studies possible, and give more insight in regional 
differences across the world. Also it creates more power to identifY smaller risk 
factors, including genetic factors. Future research on OAG will probably mostly 
be on a genetic base, in order to find more clues in its etiology and 
pathogenesis, thereby also giving more statiing-points for better therapeutic 
possibilities. 
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Samellvaftillg 
De oogaandoening "glauco om" werd reeds lang geleden voor het eerst beschreven 
en de verdere ontwikkelingen in de geschiedenis van deze aandoening worden kOlt 
belicht in hoofdstuk 1. Gedurende de laatste decades zijn de definities van de 
aandoening en ons begrip ervan fors veranderd. Intraoculaire druk, gezichtsvelden 
en papi! kenmerken werden onderkend als belangrijke factoren in het beloop van 
de aandoening. Alhoewel er steeds nieuwe onderzoeksmethoden ontwikkeld 
worden is er nog steeds weinig bekend met betrekking tot de etiologie. 
Het vroeg opsporen van de aandoening is een belangrijk algemeen 
gezondheidsprobleem. Het ontstaan van blindheid ten gevolge van glauco om kan 
voork6men worden als de aandoening vroegtijdig gediagnostiseerd en adequaat 
behandeld wordt. Wanneer echter gezichtsveld verlies is ontstaan, is er geen herstel 
meer mogelijk met de huidige therapeutische methoden. Omdat de meeste 
glaucoompatienten aanvankelijk lange tijd asymptomatisch zijn, kan er al vee! 
gezichtsveld verloren zijn op het moment dat de patient klachten ontwikkelt. Dit 
betekent dat routinematige screeningen bij asymptomatische personen nodig zijn 
om de aandoening in een vroeg stadium op te sporen. 
Er zijn veel verschillende soorten glaucoom. Primair open-kamerhoek 
glauco om (POAG) is de meest voorkomende vorm in Westerse landen. Dit 
proefschl'ift richt zich op (primair) open-kamerhoek glaucoom (OAG). Omdat we 
pseudoexfoliatie als oorzaak van glauco om niet voldoende konden uitsluiten, 
spreken we in sommige mtikelen over OAG in plaats van POAG. Aile studies 
waren gebaseerd op data van onderzoeken in het ERGO onderzoek, een 
bevolkingsonderzoek bij personen van 55 jaar en ouder. 
Een belangrijk probleem bij een aantal studies naar OAG in het verleden was 
de verschillen in criteria en methoden die geblUikt waren om glaucoom op te 
sporen en te classificeren. Deze verschillen kunnen resulteren in de verschillende 
bevindingen van deze studies en maken vergelijkingen moeilijk. Op dit moment 
wordt glaucoom gedefinieerd als een aandoening die een opticopathie veroorzaakt 
die gekarakteriseerd wordt door het uithollen van de oogzenuw (de papi!) met een 
bijbehorend gezichtsveld defect. In hoofdstuk 2 beschl'ijven we de 
prevalentiecijfers van OAG in het ERGO onderzoek. Deze getallen zijn gebaseerd 
op oogheelkundige onderzoeken bij 6781 respondenten van 55 jaar of ouder (6293 
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zelfstandig wonende respondenten en 488 wonend in verzorgingshuizen). De 
criteria voor OAG die gebruikt werden, waren gebaseerd op semi-automatische 
metingen van de papi!, zoals vel1icale cup-disk ratio (VCDR), minimale 
neuroretinale rand dikte, of asymmetrie van de VCDR tussen beide ogen, en 
gezichtsveld ondelzoeken met kinetische Goldmann perimetrie. De oogdlUk (lOP) 
werd gemeten met een Goldmann applanatie tonometer. Aile aparte criteria voor 
de diagnose OAG werden onafhankelijk van elkaar beoordeeld. Ook werden 
verschillende andere definities voor de diagnose OAG, zoals geblUikt in andere 
grote bevolkingsondelzoeken, toegepast op de data van het ERGO ondelzoek. 
Alhoewel de prevalentiecijfers, zoals deze gerapporteerd worden door de 
verschillende studies, min of meer vergelijkbaar zijn, resulteerden de verschillende 
definities toegepast op onze data in l2-voudig verschillende prevalentie cijfers 
(varierend van 0.1 tot 1.2%). Dam'Oln presenteren wij het volgende voorstel voor 
uniforme definiering en classificering van OAG in epidemiologische studies: een 
VCDR z 0.7, asymmetrie van VCDR tussen beide ogen z 0.3 of een minima Ie 
neuroretinale rand dikte < 0.10 gebruik makend van (semi-)automatische 
metingen, in combinatie met een gezichtsveld defect dat niet veroOlzaakt wordt 
door retinale of neuro-ophthalmologische oorzaken. Met deze criteria vonden we 
een prevalentie van OAG van 0.9% (95% betrouwbaarheidsinterval (Bl) 0.6, 1.1; 
56 cases). De prevalentie van OAG is !wee maal hoger bij mmmen in vergelijking 
tot vrouwen (Odds ratio 2.3, 95% Bl 1.2,4.5). Het risico voor OAG steeg met 8% 
per levensjaar (95% BI 4.0%, 13.0%). Standaardisatie van criteria en diagnostische 
methoden zal de vergelijkbaarheid van verschillende epidemiologische studies 
verbeteren, en biedt de mogelijkheid om regionale verschillen op te sporen en om 
data van verschillende studies te combineren. 
In hoofdstuk 3 beschrijven we onze bevindingen met betl-ekking tot de 
prevalentie van gezichtsveld defecten oorzaken hiervan, en de associatie met 
beperkingen hierdoor in het dagelijkse leven. De prevalentie en oOlzaken van 
gezichtsveld defecten werden cross-sectioneel bepaald. Indicatoren voor 
beperkingen in het dagelijkse leven werden zowel cross-sectioneel als prospectief 
gemeten. Gezichtsvelden werden getest met een bovendrempelige screeningstest 
van de centrale 48 graden met de Humphrey perimeter. Wanneer een defect 
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aanwezig was, dan werd de test herhaald. Kinetische Goldmann perimetrie werd 
verricht wanneer ook bij herhaling de screeningstest afWijkend was. Gegevens van 
de oogheelkundige onderzoeken, van de neurologische onderzoeken en gegevens 
van oogartsen en huisartsen werden gebruikt om de oorzaken van afWijkende 
gezichtsvelden te bepalen. Interviewgegevens met betrekking tot problemen in het 
dagelijkse leven, bij lezen, gebruik van loop hulpmiddelen, vallen en botfracturen 
werden gebruikt om de mate van beperkingen te bepalen. De prevalentie van 
gezichtsvelddefecten was 5.5%, varierend van 1.9% in de jongste leeftijdscategorie 
tot 17.0% in de oudste leeftijdscategorie. Glaucoom was de belangrijkste oorzaak 
voor gezichtsvelddefecten in aile leeftijdsgroepen. Andere oogzenuwpathologie en 
cerebrovasculaire aandoeningen stonden op de tweede en derde plaats. Na het 
75ste levensjaar waren stonden leeftijdsgebonden maculadegeneratie en retinale 
vasculaire occlusies op de tweede en derde plaats. Gezichtsveldverlies was, 
onafhankelijk van een verminderde gezichtsscherpte, geassocieerd met 
beperkingen in het dagelijkse leven en een hogere kans op vallen en bot fracturen. 
In 28% van aile personen met gezichtsveld verlies waren deze personen hiervan 
niet op de hoogte en hadden ze nog nooit een oogarts bezocht behalve voor een 
bril. 
Over de genetische achtergrond van OAG is nog steeds zeer weinig bekend, 
alhoewel genetische faktoren al van belang werden geacht sinds 1869 door von 
Graefe. Veel uitgebreide stambomen zijn gepubliceerd sinds die tijd, meestal in 
geseJecteerde populaties, en resulterend in verschillende inzichten met betrekking 
tot overeving. Vaak werd in deze studies aileen anamnestische familieanamnese 
data gebruikt en werden de familieleden niet echt onderzocht. In hoofdstuk 4 
beschrijven we een studie waarin we bepaalden of OAG aggregeert in families in 
de algemene bevolking. Hiervoor selecteerden we aile OAG cases en een random 
selectie van controle personen uit het ERGO bevolkingsonderzoek. Van deze 
personen werden de eerstegraads familieleden onderzocht volgens een 
gestandaardiseerd protocol. Bij broers en zusters van OAG cases vonden we een 
OAG prevalentie van 10.4% en bij kinderen van OAG cases was de prevalentie 
l.l %. In de controlegroep waren deze prevalentiecijfers respectievelijk 0.7% en 
0%. Het lifetime risico voor een verhoogde lOP was 42.5% bij familieleden van 
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OAG cases ten opzichte van 6.7% bij familieleden van controles; voor een grote 
VCDR 62.2% versus 16.6%; en voor OAG 22.0% versus 2.3%, resulterend in een 
relatiefrisico van 9.2 (95% Bl1.2, 73.9). Het populatie-attributiefrisico voor OAG 
was 16.4%. Concluderend hebben familieleden van OAG cases een sterk verhoogd 
risico voor OAG. Verrassend genoeg was niet lOP maar een vergroting van de 
VCDR het eerste en meest prominente teken van familie aggregatie. VerdeI' 
onderzoek is no dig om de genetische achtergrond van het verhoogde familierisico 
van OAG te ontrafelen. 
Een betrouwbare bepaling van de verticale cup-disc ratio (VCDR) is 
noodzakelijk voor de diagnose en behandeling van OAG. Echter, funduscopische 
VCDR bepalingen zijn bekend om hun lage interobserver overeenkomst. De recent 
geintroduceerde semi-automatische beeld analyse apparatuur heeft een betere 
reproduceerbaarheid en kan kleine veranderingen in de tijd eerder detecteren. Op 
dit moment is funduscopie, ondanks de lagere reproduceerbaarheid, nog steeds de 
belangrijkste screeningsmethode voor het opsporen van OAG. In hoofdstuk 5 
vergelijken we de funduscopische met de semi-automatische VCDR metingen. De 
gemiddelde fimduscopische VCDR van 5143 respondenten was 0.30 (SE 0.0021; 
range 0.00, 1.00); de gemiddelde semi-automatisch gemeten VCDR was 0.49 (SE 
0.0019; range 0.04, 0.86; verschi! 0.19; p<O.OOO I). De correlatie tussen beide 
methoden was matig (correlatie coefficient 0.61, SE 0.11), en was lager bij kleine 
papillen. Met de semi-automatische VCDR metingen werd 76% van de OAG cases 
correct geidentificeerd (waarbij gezichtsveld gegevens en funduscopische papi! 
karakteristieken werden gebruikt om OAG te definieren). Bij de semi-automatische 
metingen was er een kleinere variabiliteit in vergelijking met funduscopie. VerdeI' 
zijn de semi-automatische metingen betel' gestandardiseerd, hetgeen van belang is 
bij epidemiologische studies en follow-up onderzoeken. De 97.5de percentiel van 
de VCDR distributie was zowel VOOI' de semi-automatische metingen als voor 
oogspiegelen 0.70. 
De lOP wordt gebruikt voor de diagnostiek en behandeling van OAG. 
Goldmatm applanatie tonomeirie is de gouden standaard, maar deze geeft slechts 
een schatting van de echte lOP. De nauwkeurigheid van deze schatting is 
afhankelijk van vele factoren. Tot op zekere hoogte kunnen fouten voorkomen 
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worden door een juiste meettechniek. Maar fouten veroorzaakt door andere 
factoren, zoals met name centrale cornea dikte die de stugheid van de cornea 
beinvloedt, kunnen niet voorkomen worden. Centrale corneadikte kan gemeten 
worden door middel van een optische methode en met behulp van ultrageluid. 
Deze laatste methode is betl'Ouwbaarder. Het is gebleken dat ultrasone pachymetrie 
zeer nauwkeurig is en repl'Oduceerbaar met een lagere inter- en intra-observer 
variabiliteit dan optische pachymetrie. In hoofdstuk 6 presenteren we gegevens 
over de centrale corneadikte bij een gerandomiseerd geselecteerde subgl'Oep van 
personen van het ERGO ondelzoek. Bij 395 personen (352 contl'Oles, 13 personen 
met oculaire hypertensie en 30 cases met POAG) van 55 jaar en ouder, werd de 
centrale corneadikte gemeten met behulp van ultrasone pachymetrie (Allergan 
Humphrey 850) en de lOP met de Goldmann applanatie tonometer. De gemiddelde 
centrale corneadikte van de contl'Olegl'Oep was 537.4 [tm (95% Betl'Ouwbaarheids 
Interval (BI) 533.8,540.9; bereik 427-620 [tm). Oit was nagenoeg hetzelfde voor 
zowel het linker als het rechter oog, met een maximaal verschil van 42 [tm. Er was 
geen verschil tussen de geslachten en er was geen significant verband met leeftijd. 
Lineaire regressie analyse van de centrale corneadikte ten opzichte van lOP liet een 
toename van 0.19 mmHg in de lOP zien bij iedere 10 [tm toename van de centrale 
corneadikte (95% BI 0.09, 0.28). Dit verband was gelijk voor beide ogen en voor 
be ide geslachten. De 13 personen met oculaire hypertensie hadden een 16.0 [1m 
(95% BI -2.6, +34.6) dikkere cornea dan de controlegroep (p=0.093), telwijl 
daarentegen de 30 personen met POAG een 21.5 [tm (95% BI 8.8, 34.1) dunnere 
cornea hadden in vergelijking tot de contl'Olegroep (P=O.OOI). Concluderend kan 
gezegd worden dat de lOP gemeten door middel van applanatie tonometrie positief 
gerelateerd is aan de centrale corneadikte. Door dit onderzoek kan niet uitgesloten 
worden of dit aileen door meetfouten wordt veroorzaakt, of mede wordt 
veroOlzaakt door een direct effect van de lOP op de corneadikte. Als gevolg van 
de variatie in de centrale corneadikte in de populatie kan de gemeten lOP een 
onder- of een overschatting van de echte hydrostatische lOP zijn. Dus: de centrale 
corneadikte kan een confounder zijn bij het onderscheid tussen een normale en een 
verhoogde lOP, en dam'door ook tussen normotensiefen een hypertensief POAG, 
wanneer een absoluut aflcappunt van 21 mmHg gehanteerd wordt. 
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Diagnostische mydriatica worden vee! gebruikt in de klinische ooghee!kundige 
praktijk. In de meeste gevallen zijn ze essentieel voor een adequaat onderzoek van 
de oculaire media en de fundus, met name bij niet-oogartsen. Echter het gebruik 
van pupilvelwijdende middelen kan een aanval van acuut kamerhoek-afsluitings 
glaucoom (acute angle-closure glaucoma, AACG) uitlokken, met een stijging van 
de lOP tot 80 mmHg binnen enkele uren, met het bijkomend risico van blijvende 
schade aan de oogzenuw. Dit gevaar een AACG-aanval te veroorzaken kan een 
reden zijn waarom vee! huisat1sen, internisten en andere (niet-oog)at1sen niet graag 
pupillen verwijden voor oogonderzoek. Tevens kan dit bias veroorzaken bij het 
selecteren van deelnemers aan een oogheelkundig epidemiologisch onderzoek. In 
hoofdstuk 7 besclU'ijven we het risico op het uitlokken van AACG bij een 
screeningsprotocol voor OAG. In totaal 6760 personen namen deel aan het 
oogheelkundig onderzoek en 6679 (98,8%) van hen kregen tropic amide 0,5% en 
phenylephrine 5% oogdruppels toegediend voor diagnostische pupilverwijding. Er 
was geen se!ectie gemaakt op basis van bijvoorbeeld oogdruk, aanwezigheid van 
een nauwe voorste oogkamer, of de aanwezigheid van glauco om in de 
voorgeschiedenis. Na het oogheelkundig onderzoek kregen aile deelnemers 
thymoxamine 0,5% druppels in beide ogen toegediend en werden ze 
gewaarschuwd voor de symptomen van AACG. In twee gevallen ontwikke!de zich 
een aanval van AACG in een ~Og. Beide cases werden om te beginnen behandeld 
met thymoxamine 0,5% oogdruppels en oraal acetazolamide 0.500. Vervolgens 
werd een perifere iridotomie verricht met een Nd-Y AG-Iaser, en beide ogen 
genazen zonder restverschijnse!en. Deze studie toont aan dat, bij niet-geselecteerde 
(Kaukasische) personen van 55 jaar of ouder, het l'isico op AACG na dit soort 
diagnostische pupilvelwijding slechts 0,03% is. Daarom beschouwen wij 
pupilvelwijding met bovengenoemde mydriatica als een relatiefveilige procedure, 
vooropgesteld dat iedereen vooraf grondig geinformeerd is over de gerelateerde 
klachten en dat medische zorg beschikbaar is voor her-onderzoek van de personen 
in geval van klachten. 
In hoofdstuk 8 worden aile resultaten in een groter perspectief bekeken. Er 
wordt een voorste! gedaan tot standaardisatie van OAG-diagnostiek en classificatie 
in epidemiologische studies. Gestandaardiseerde onderzoeks algoritmen en 
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definities maakt het vergelijken en samenvoegen van gegevens uit verschillende 
onderzoeken mogelijk, en geeft meer inzicht in regionale verschillen over de hele 
wereld. Ook kunnen zo betel' kleinere risicofactoren geYdentificeerd worden, 
inclusief genetische factoren. Toekomstig onderzoek naar OAG zal waarschijnlijk 
vool'llamelijk op genetische grondslagen gericht zijn, om zo meer aanwijzingen 
over etiologie en pathogenese te krijgen, en daarbij ook meer aangrijpingspunten 
voor betere behandelingsmogelijkheden. 
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Dit proefschrift kwam tot stand dank zij de samenwerking tussen verschillende 
instituten en personen. Graag bedank ik al deze personen voor hun bijdragen. 
Een aantal zal ik hier bij naam noemen. 
Allereerst wi! ik professor de Jong danken voor de gelegenheid die hij mij 
heeft gegeven om in de oogheelkunde terecht te komen. Beste Paulus, in het 
wetenschappelijk werk was je altijd open-minded en kritisch. Met name toen je 
nog in Rotterdam werkzaam was, konden we altijd 'binnenlopen' voor vragen 
op oogheelkllndige en andere terreinen; na je vertrek naar Amsterdam ging dit 
aanvankelijk wat moeizamer, maar na het herontdekken van de email leverde 
dit ook geen problem en meer op. Ondanks de drukke bezigheden bij de 
reorganisatie van het 101 konden we steeds rekenen op snelle reacties en 
correcties van manuscripten. lk wi! je heel erg bed an ken voor het in mij 
gestelde vertrouwen. Verder heb ik inderdaad twee jaar lang ervaren, dat het 
combineren van klinisch werk en aft'onden van een proefschrift geen goede 
combinatie is (zoals jij altijd al zei). 
Mijn tweede promotor, professor Hofman, ben ik zeer erkentelijk voar de 
epidemiologische opleiding en begeleiding. Beli, je vermogen om 
epidemiologische problemen begrijpelijk te rna ken en je structurering waren 
heel zinvol en vaak noodzakelijk tijdens de vele werkbesprekingen met de hele 
oogheelkllnde groep. 
De hlilp van dr. C.M. van DlIijn was onontbeerlijk bij het opzetten van ons 
fami!ieonderzoek. Beste Cock, dankzij jouw belangrijke bijdragen is dit een 
lInieke stlldie geworden en heeft dit mooie resultaten opgeleverd (en uiteraard 
een mooie pllblicatie). 
Lous Ruempol, als secretaresse van Paulus was je aan het begin van mijn 
werkzaamheden in Rotterdam mijn eerste aanspreekpllnt. Jouw hlilp bij 
organisatorische en administratieve problemen was altijd effectief en voor mij 
heel welkom. De samenwerking was steeds heel hartelijk en gezellig. lk hoop 
dat je nu op je nieuwe werkplek veel plezier in je werk hebt. 
Douwe Bakker (Academisch Medisch Centrum, Amsterdam), professor 
Jonas (Erlangen, Duitsland) en zijn echtgenote wi! ik bedanken voor de hulp bij 
147 
Dankwoord 
het beoordelen van die honderden gezichtsveld-onderzoeken van aile ERGO 
deelnemers en hun familieleden. Zonder hun expertise op dit gebied zou de 
waarde van al deze onderzoeken veel mindel' zijn geweest. 
Uiteraard mag ik Ada en Corina niet vergeten. Zij waren het die ~ns in 
ERGO assisteerden met aile oogonderzoeken en deze zelf ook veelvuldig 
hebben verricht. Daarnaast hebben zij ontzettend veel werk verzet bij het 
opsporen van aile familieleden in het familieonderzoek. Het leek af en toe weI 
'Opsporing verzocht' of 'Spoorloos' op onze kameI'. Naast jullie kundige hulp 
was het ook zeer gezellig om met jullie samen te werken. Het uitvoeren van de 
oogonderzoeken bij familieleden thuis (van Groningen tot Maastricht) was 
zonder jullie niet mogelijk geweest, en het grote aantal kilometers op de weg 
een stuk minder aangenaam. 
Anneke Korving, jou wil ik bedanken voor je aanwezigheid in het ERGO 
centrum om aile deelnemers en hun familieleden te ontvangen en om aile 
telefoontjes voor ons te beantwoorden. Daarnaast konden we ook altijd op je 
rekenen als helpende hand bij de oogonderzoeken. 
Gerard de Bruijne en Margriet van Rees hebben aile dia's van oogzenuwen 
ingelezen in de computer en aile metingen verricht. Ik wil jullie heel erg 
bedanken voor dit mOlmiken-werk dat jullie onder begeleiding van Raan 
Ramrattan hebben verricht. Raan, jouw papil-metingen waren voor enkele 
hoofdstukken van dit proefschrift van zeer veel waarde. 
Caroline Klaver, als collega in de eerste follow-up fase van ERGO en het 
familieonderzoek dat we samen 'gerund' hebben, hebben we elkaar redelijk 
goed leren kennen. Ik heb vaak mogen profiteren van je grote epidemiologische 
kennis en vaardigheden in de Engelse taal. Ik ben blij je nu ook als collega in 
Dijkzigt te hebben. 
Raan Ramrattan en Jacqueline Assink hebben mijn werkzaamheden (en die 
van Caroline Klaver) in ERGO over genomen. Jullie hebben uiteindelijk hulp 
gekregen van Caroline Hulsman en Petra Borger, waarmee het glaucoom 
onderzoek flink versterkt wordt. Ik ben blij met de prettige en vlotte manier 
waarop dit belangrijke werk door jullie is overgenomen en de goede 
samenwerking. 
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Hans Vingerling en Ida Dielemans bedank ik voor al het werk dat ze gedaan 
hebben om in de beginfase van ERGO het hele oogonderzoek op poten te 
zetten. 
Uiteraard mag ik niet vergeten om aile deelnemers van het ERGO onderzoek 
te bedanken voor hun medewerking. VerdeI' ook dank aan aile familieleden van 
ERGO deelnemers, die vaak een hele dag aan het reizen waren om mee te doen 
aan ons familieonderzoek. Ook aile medewerkers aan het ERGO onderzoek die 
ik niet bij name heb genoemd bedank ik voor al hun werk en ondersteuning. 
Aile stafleden en andere medewerkers van de afdeling oogheelkunde van het 
Academisch Ziekenhuis Rotterdam ben ik dank verschuldigd voor de 
gelegenheid en het begrip die ik kreeg om dit proefschrift af te ronden tijdens 
mijn opleiding. 
Tenslotte mijn ouders en mijn zus: hen bedank ik voor aile betrokkenheid, 
stimulering en steun die ik steeds mocht ontvangen. Ook als het allemaal niet 
mee zat kOIl ik steeds weer op jullie rekellen, en zOllder jullie zou dit 
proefschrift niet mogelijk zijn geweest. 
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